| Year |
Citation |
Score |
| 2024 |
Machado-Vieira R, Jones GH, Courtes AC, Ruiz AC, Vecera CM, Henter ID, Lane SD, Zarate CA, Soares JC. The effect of intranasal (R,S)-ketamine on symptoms of fatigue in severe major depressive disorder or bipolar depression with and without comorbid alcohol use disorder: Results from a randomized, double-blind, placebo-controlled trial. Journal of Affective Disorders. 367: 281-285. PMID 39214377 DOI: 10.1016/j.jad.2024.08.183 |
0.373 |
|
| 2024 |
Raja SM, Guptill JT, Mack M, Peterson M, Byard S, Twieg R, Jordan L, Rich N, Castledine R, Bourne S, Wilmshurst M, Oxendine S, Avula SGC, Zuleta H, Quigley P, ... ... Zarate CA, et al. A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers. Clinical Pharmacology and Therapeutics. PMID 39054770 DOI: 10.1002/cpt.3391 |
0.597 |
|
| 2024 |
Johnston JN, Zarate CA, Kvarta MD. Esketamine in depression: putative biomarkers from clinical research. European Archives of Psychiatry and Clinical Neuroscience. PMID 38997425 DOI: 10.1007/s00406-024-01865-1 |
0.362 |
|
| 2024 |
Moses RG, Jodarski C, Setzer M, Lewis KL, Yan J, Byers S, Yavi M, Ballard ED, Walkiewicz M, Zarate CA, Austin JC, Similuk M. Psychological state at the time of psychiatric genetic counseling impacts patient empowerment: A pre-post analysis. Journal of Genetic Counseling. PMID 38987885 DOI: 10.1002/jgc4.1949 |
0.35 |
|
| 2024 |
Lee Y, Gilbert JR, Waldman L, Zarate CA, Ballard ED. Potential association between suicide risk, aggression, impulsivity, and the somatosensory system. Social Cognitive and Affective Neuroscience. PMID 38874947 DOI: 10.1093/scan/nsae041 |
0.606 |
|
| 2024 |
Jones GH, Vecera CM, Ruiz AC, Wu HE, McInturff SI, Orejarena MJ, Smith KA, Soares JC, Zarate CA, Lane SD, Machado-Vieira R. A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder. The Journal of Clinical Psychiatry. 85. PMID 38696221 DOI: 10.4088/JCP.23m14974 |
0.387 |
|
| 2024 |
Quintanilla B, Zarate CA, Pillai A. Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects? Molecular Psychiatry. PMID 38575806 DOI: 10.1038/s41380-024-02507-7 |
0.374 |
|
| 2024 |
Evans JW, Graves MC, Nugent AC, Zarate CA. Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers. Scientific Reports. 14: 4538. PMID 38402253 DOI: 10.1038/s41598-024-54370-9 |
0.368 |
|
| 2024 |
Ballard ED, Nischal RP, Burton CR, Greenstein DK, Anderson GE, Waldman LR, Zarate CA, Gilbert JR. Clinical and electrophysiological correlates of hopelessness in the context of suicide risk. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 80: 38-45. PMID 38310748 DOI: 10.1016/j.euroneuro.2023.12.002 |
0.601 |
|
| 2024 |
Fountoulakis KN, Tohen M, Zarate CA. Pharmacodynamic properties of lumateperone and its efficacy in acute bipolar depression: a mechanistic hypothesis based on data. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 81: 1-9. PMID 38310714 DOI: 10.1016/j.euroneuro.2024.01.002 |
0.371 |
|
| 2023 |
Alexander L, Hawkins PCT, Evans JW, Mehta MA, Zarate CA. Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals. Translational Psychiatry. 13: 371. PMID 38040678 DOI: 10.1038/s41398-023-02674-1 |
0.315 |
|
| 2023 |
Lamontagne SJ, Gilbert JR, Zabala PK, Waldman LR, Zarate CA, Ballard ED. Clinical, behavioral, and electrophysiological profiles along a continuum of suicide risk: evidence from an implicit association task. Psychological Medicine. 1-10. PMID 37997749 DOI: 10.1017/S0033291723003331 |
0.594 |
|
| 2023 |
Wang PR, Yavi M, Lee H, Kotb Y, Shora L, Park LT, Zarate CA. An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression. Journal of Clinical Psychopharmacology. 43: 422-427. PMID 37683231 DOI: 10.1097/JCP.0000000000001738 |
0.389 |
|
| 2023 |
Punturieri C, Duncan WC, Greenstein D, Shandler G, Zarate CA, Evans JW. An exploration of actigraphy in the context of ketamine and treatment-resistant depression. International Journal of Methods in Psychiatric Research. e1984. PMID 37668277 DOI: 10.1002/mpr.1984 |
0.363 |
|
| 2023 |
Nikolin S, Rodgers A, Schwaab A, Bahji A, Zarate C, Vazquez G, Loo C. Ketamine for the treatment of major depression: a systematic review and meta-analysis. Eclinicalmedicine. 62: 102127. PMID 37593223 DOI: 10.1016/j.eclinm.2023.102127 |
0.378 |
|
| 2023 |
Machado-Vieira R, Courtes AC, Zarate CA, Henter ID, Manji HK. Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder. Frontiers in Neuroscience. 17: 1228455. PMID 37592949 DOI: 10.3389/fnins.2023.1228455 |
0.33 |
|
| 2023 |
Kotoula V, Evans JW, Punturieri CE, Zarate CA. Review: The use of functional magnetic resonance imaging (fMRI) in clinical trials and experimental research studies for depression. Frontiers in Neuroimaging. 2: 1110258. PMID 37554642 DOI: 10.3389/fnimg.2023.1110258 |
0.387 |
|
| 2023 |
Wang PR, Yavi M, Lee H, Kotb Y, Shora L, Park LT, Zarate CA. An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression. Journal of Clinical Psychopharmacology. PMID 37498092 DOI: 10.1097/JCP.0000000000001738 |
0.389 |
|
| 2023 |
Johnston JN, Kadriu B, Kraus C, Henter ID, Zarate CA. Ketamine in neuropsychiatric disorders: an update. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 37340091 DOI: 10.1038/s41386-023-01632-1 |
0.328 |
|
| 2023 |
Kraus C, Kautzky A, Watzal V, Gramser A, Kadriu B, Deng ZD, Bartova L, Zarate CA, Lanzenberger R, Souery D, Montgomery S, Mendlewicz J, Zohar J, Fanelli G, Serretti A, et al. Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database. Journal of Affective Disorders. 335: 349-357. PMID 37196934 DOI: 10.1016/j.jad.2023.05.042 |
0.322 |
|
| 2023 |
Fountoulakis KN, Ioannou M, Tohen M, Haarman BCM, Zarate CA. Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 72: 30-39. PMID 37060629 DOI: 10.1016/j.euroneuro.2023.03.009 |
0.354 |
|
| 2023 |
Quintanilla B, Medeiros GC, Greenstein D, Yuan P, Johnston JN, Park LT, Goes FS, Gould TD, Zarate CA. κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine. Journal of Clinical Psychopharmacology. 43: 89-96. PMID 36821406 DOI: 10.1097/JCP.0000000000001663 |
0.31 |
|
| 2023 |
Johnston JN, Greenwald MS, Henter ID, Kraus C, Mkrtchian A, Clark NG, Park LT, Gold P, Zarate CA, Kadriu B. Inflammation, stress and depression: an exploration of ketamine's therapeutic profile. Drug Discovery Today. 103518. PMID 36758932 DOI: 10.1016/j.drudis.2023.103518 |
0.749 |
|
| 2023 |
Johnston JN, Kadriu B, Allen J, Gilbert JR, Henter ID, Zarate CA. Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment. Neuropharmacology. 109422. PMID 36646310 DOI: 10.1016/j.neuropharm.2023.109422 |
0.617 |
|
| 2022 |
Bahji A, Vazquez GH, Zarate CA. Response to "Letter to the Editor: Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.". Journal of Affective Disorders. 324: 68. PMID 36574849 DOI: 10.1016/j.jad.2022.12.068 |
0.316 |
|
| 2022 |
Price RB, Kissel N, Baumeister A, Rohac R, Woody ML, Ballard ED, Zarate CA, Deakin W, Abdallah CG, Feder A, Charney DS, Grunebaum MF, Mann JJ, Mathew SJ, Gallagher B, et al. International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators. Molecular Psychiatry. PMID 36071111 DOI: 10.1038/s41380-022-01757-7 |
0.375 |
|
| 2022 |
Bloomfield-Clagett B, Ballard ED, Greenstein DK, Wilkinson ST, Grunebaum MF, Murrough JW, Mathew SJ, Phillips JL, Fava M, Sanacora G, Zarate CA. A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Non-Suicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine. The International Journal of Neuropsychopharmacology. PMID 35994774 DOI: 10.1093/ijnp/pyac055 |
0.352 |
|
| 2022 |
Gilbert JR, Gerner JL, Burton CR, Nugent AC, Zarate CA, Ballard ED. Magnetoencephalography biomarkers of suicide attempt history and antidepressant response to ketamine in treatment-resistant major depression. Journal of Affective Disorders. PMID 35728680 DOI: 10.1016/j.jad.2022.06.025 |
0.683 |
|
| 2022 |
Yavi M, Lee H, Henter ID, Park LT, Zarate CA. Ketamine treatment for depression: a review. Discover Mental Health. 2: 9. PMID 35509843 DOI: 10.1007/s44192-022-00012-3 |
0.395 |
|
| 2022 |
Kojic M, Saelens J, Kadriu B, Zarate CA, Kraus C. Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics. Current Topics in Behavioral Neurosciences. PMID 35312993 DOI: 10.1007/7854_2022_313 |
0.338 |
|
| 2022 |
Gilbert JR, Wusinich C, Zarate CA. A Predictive Coding Framework for Understanding Major Depression. Frontiers in Human Neuroscience. 16: 787495. PMID 35308621 DOI: 10.3389/fnhum.2022.787495 |
0.65 |
|
| 2022 |
Fountoulakis KN, Tohen M, Zarate CA. Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 54: 100-115. PMID 34980362 DOI: 10.1016/j.euroneuro.2021.10.003 |
0.36 |
|
| 2021 |
Kheirkhah M, Baumbach P, Leistritz L, Witte OW, Walter M, Gilbert JR, Zarate CA, Klingner CM. The Right Hemisphere Is Responsible for the Greatest Differences in Human Brain Response to High-Arousing Emotional versus Neutral Stimuli: A MEG Study. Brain Sciences. 11. PMID 34439579 DOI: 10.3390/brainsci11080960 |
0.574 |
|
| 2021 |
Gilbert JR, Galiano CS, Nugent AC, Zarate CA. Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression. Frontiers in Psychiatry. 12: 673159. PMID 34220581 DOI: 10.3389/fpsyt.2021.673159 |
0.697 |
|
| 2021 |
Fagerholm ED, Leech R, Williams S, Zarate CA, Moran RJ, Gilbert JR. Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression. Translational Psychiatry. 11: 335. PMID 34052834 DOI: 10.1038/s41398-021-01442-3 |
0.69 |
|
| 2021 |
Bahji A, Zarate CA, Vazquez GH. Ketamine for bipolar depression: a systematic review. The International Journal of Neuropsychopharmacology. PMID 33929489 DOI: 10.1093/ijnp/pyab023 |
0.402 |
|
| 2021 |
Henter ID, Park LT, Zarate CA. Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status. Cns Drugs. PMID 33904154 DOI: 10.1007/s40263-021-00816-x |
0.329 |
|
| 2021 |
Zarate CA. Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437211004023. PMID 33739187 DOI: 10.1177/07067437211004023 |
0.313 |
|
| 2021 |
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, ... ... Zarate CA, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. The American Journal of Psychiatry. appiajp202020081251. PMID 33726522 DOI: 10.1176/appi.ajp.2020.20081251 |
0.387 |
|
| 2021 |
Ballard ED, Gilbert JR, Wusinich C, Zarate CA. New Methods for Assessing Rapid Changes in Suicide Risk. Frontiers in Psychiatry. 12: 598434. PMID 33574775 DOI: 10.3389/fpsyt.2021.598434 |
0.595 |
|
| 2020 |
Kadriu B, Greenwald M, Henter ID, Gilbert JR, Kraus C, Park LT, Zarate CA. Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants. The International Journal of Neuropsychopharmacology. PMID 33252694 DOI: 10.1093/ijnp/pyaa087 |
0.623 |
|
| 2020 |
Bahji A, Vazquez GH, Zarate CA. Erratum to "Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis" [Journal of Affective Disorders 278C (2021) 542-555]. Journal of Affective Disorders. PMID 33229028 DOI: 10.1016/j.jad.2020.11.103 |
0.323 |
|
| 2020 |
Ballard ED, Gilbert JR, Fields JS, Nugent AC, Zarate CA. Network Changes in Insula and Amygdala Connectivity Accompany Implicit Suicidal Associations. Frontiers in Psychiatry. 11: 577628. PMID 33192714 DOI: 10.3389/fpsyt.2020.577628 |
0.594 |
|
| 2020 |
Lundin NB, Sepe-Forrest L, Gilbert JR, Carver FW, Furey ML, Zarate CA, Nugent AC. Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder. Journal of Affective Disorders. 279: 239-249. PMID 33074143 DOI: 10.1016/j.jad.2020.10.007 |
0.836 |
|
| 2020 |
Bahji A, Vazquez GH, Zarate CA. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis. Journal of Affective Disorders. 278: 542-555. PMID 33022440 DOI: 10.1016/j.jad.2020.09.071 |
0.385 |
|
| 2020 |
Mkrtchian A, Evans JW, Kraus C, Yuan P, Kadriu B, Nugent AC, Roiser JP, Zarate CA. Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals. Molecular Psychiatry. PMID 32929215 DOI: 10.1038/S41380-020-00878-1 |
0.81 |
|
| 2020 |
Acevedo-Diaz EE, Cavanaugh GW, Greenstein D, Kraus C, Kadriu B, Park L, Zarate CA. Can 'floating' predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression. Journal of Psychiatric Research. 130: 280-285. PMID 32861983 DOI: 10.1016/J.Jpsychires.2020.06.012 |
0.492 |
|
| 2020 |
Nugent AC, Ballard ED, Gilbert JR, Tewarie PK, Brookes MJ, Zarate CA. Multilayer MEG functional connectivity as a potential marker for suicidal thoughts in major depressive disorder. Neuroimage. Clinical. 28: 102378. PMID 32836087 DOI: 10.1016/J.Nicl.2020.102378 |
0.706 |
|
| 2020 |
Gilbert JR, Zarate CA. Biologically plausible models of neural dynamics for rapid-acting antidepressant interventions. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32801348 DOI: 10.1038/S41386-020-00804-7 |
0.602 |
|
| 2020 |
Ching CRK, Hibar DP, Gurholt TP, Nunes A, Thomopoulos SI, Abé C, Agartz I, Brouwer RM, Cannon DM, de Zwarte SMC, Eyler LT, Favre P, Hajek T, Haukvik UK, Houenou J, ... ... Zarate CA, et al. What we learn about bipolar disorder from large-scale neuroimaging: Findings and future directions from the ENIGMA Bipolar Disorder Working Group. Human Brain Mapping. PMID 32725849 DOI: 10.1002/Hbm.25098 |
0.351 |
|
| 2020 |
Park LT, Luckenbaugh DA, Pennybaker SJ, Hopkins MA, Henter ID, Lener MS, Kadriu B, Ballard ED, Zarate CA. The Effects of Ketamine on Typical and Atypical Depressive Symptoms. Acta Psychiatrica Scandinavica. PMID 32677051 DOI: 10.1111/acps.13216 |
0.331 |
|
| 2020 |
Nugent AC, Ballard ED, Gilbert JR, Tewarie PK, Brookes MJ, Zarate CA. The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder. Frontiers in Psychiatry. 11: 519. PMID 32655423 DOI: 10.3389/Fpsyt.2020.00519 |
0.717 |
|
| 2020 |
Kadriu B, Ballard ED, Henter ID, Murata S, Gerlus N, Zarate CA. Neurobiological biomarkers of response to ketamine. Advances in Pharmacology (San Diego, Calif.). 89: 195-235. PMID 32616207 DOI: 10.1016/Bs.Apha.2020.05.003 |
0.418 |
|
| 2020 |
Schmaal L, Pozzi E, C Ho T, van Velzen LS, Veer IM, Opel N, Van Someren EJW, Han LKM, Aftanas L, Aleman A, Baune BT, Berger K, Blanken TF, Capitão L, Couvy-Duchesne B, ... ... Zarate C, et al. ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. Translational Psychiatry. 10: 172. PMID 32472038 DOI: 10.1038/S41398-020-0842-6 |
0.352 |
|
| 2020 |
Kadriu B, Deng ZD, Kraus C, Henter ID, Lisanby SH, Zarate CA. Not So Fast: Recent Successes and Failures in Treating Depression. The Journal of Clinical Psychiatry. 81. PMID 32459405 DOI: 10.4088/Jcp.19Ac13138 |
0.428 |
|
| 2020 |
Zarate CA. Ketamine: a new chapter in antidepressant development. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 32401872 DOI: 10.1590/1516-4446-2020-1000 |
0.306 |
|
| 2020 |
Farmer CA, Gilbert JR, Moaddel R, George J, Adeojo L, Lovett J, Nugent AC, Kadriu B, Yuan P, Gould TD, Park LT, Zarate CA. Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32376872 DOI: 10.1038/s41386-020-0699-7 |
0.645 |
|
| 2020 |
Farmer CA, Gilbert JR, Moaddel R, George J, Adeojo L, Lovett J, Nugent AC, Kadriu B, Yuan P, Gould TD, Park LT, Zarate CA. Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32252062 DOI: 10.1038/S41386-020-0663-6 |
0.646 |
|
| 2020 |
Park LT, Kadriu B, Gould TD, Zanos P, Greenstein D, Evans JW, Yuan P, Farmer CA, Oppenheimer M, George JM, Adeojo LW, Snodgrass HR, Smith MA, Henter ID, Machado-Vieira R, ... ... Zarate CA, et al. A Randomized Trial of the N-methyl-d-aspartate Receptor Glycine Site Antagonist Prodrug 4-chlorokynurenine in Treatment-Resistant Depression. The International Journal of Neuropsychopharmacology. PMID 32236521 DOI: 10.1093/Ijnp/Pyaa025 |
0.415 |
|
| 2020 |
Kraus C, Mkrtchian A, Kadriu B, Nugent AC, Zarate CA, Evans JW. Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31995812 DOI: 10.1038/S41386-020-0624-0 |
0.763 |
|
| 2020 |
Ardalan M, Elfving B, Rafati AH, Mansouri M, Zarate CA, Mathe AA, Wegener G. Rapid effects of S-ketamine on the morphology of hippocampal astrocytes and BDNF serum levels in a sex-dependent manner. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 31973999 DOI: 10.1016/J.Euroneuro.2020.01.001 |
0.367 |
|
| 2020 |
Gilbert JR, Zarate CA. Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation. Pharmacology, Biochemistry, and Behavior. 172856. PMID 31958471 DOI: 10.1016/J.Pbb.2020.172856 |
0.706 |
|
| 2020 |
Nugent AC, Ballard ED, Gilbert JR, Tewarie PK, Brookes MJ, Zarate CA. The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder Frontiers in Psychiatry. 11. DOI: 10.3389/fpsyt.2020.00519 |
0.708 |
|
| 2020 |
Wusinich C, Gilbert JR, Mustafa NL, Zarate CA. Electrophysiological Correlates of the Monetary Incentive Delay Task in Mood Disorders Biological Psychiatry. 87: S282. DOI: 10.1016/J.Biopsych.2020.02.728 |
0.627 |
|
| 2020 |
Mustafa N, Wusinich C, Gilbert J, Luber B, Halberstadt A, Lisanby S, Zarate C, Deng Z. Using Mnemonic Similarity Task to Assess Medial Temporal Lobe Function: A Magnetoencephalography Study Biological Psychiatry. 87: S237-S238. DOI: 10.1016/J.Biopsych.2020.02.616 |
0.591 |
|
| 2020 |
Gilbert J, Ballard E, Fields J, Zarate C. Electrophysiological Correlates of the Suicide Implicit Association Task Biological Psychiatry. 87: S169. DOI: 10.1016/J.Biopsych.2020.02.447 |
0.617 |
|
| 2020 |
Punturieri C, Evans J, Zarate C. Variations in Estimated Biological Brain Age in Treatment-Resistant Depression Biological Psychiatry. 87: S461. DOI: 10.1016/J.Biopsych.2020.02.1173 |
0.386 |
|
| 2020 |
Ballard E, Gilbert J, Fields J, Farmer C, Zarate C. Mood Induction Paradigm in a Depressed Patient Sample Using Magnetoencephalography Biological Psychiatry. 87: S416. DOI: 10.1016/J.Biopsych.2020.02.1062 |
0.704 |
|
| 2019 |
Park LT, Falodun TB, Zarate CA. Ketamine for Treatment-Resistant Mood Disorders. Focus (American Psychiatric Publishing). 17: 8-12. PMID 31975953 DOI: 10.1176/appi.focus.20180030 |
0.368 |
|
| 2019 |
Gilbert JR, Ballard ED, Galiano CS, Nugent AC, Zarate CA. Magnetoencephalographic Correlates of Suicidal Ideation in Major Depression. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31928949 DOI: 10.1016/J.Bpsc.2019.11.011 |
0.7 |
|
| 2019 |
Acevedo-Diaz EE, Cavanaugh GW, Greenstein D, Kraus C, Kadriu B, Zarate CA, Park LT. Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression. Journal of Affective Disorders. PMID 31791675 DOI: 10.1016/J.Jad.2019.11.028 |
0.425 |
|
| 2019 |
Ballard ED, Farmer CA, Shovestul B, VandeVoort J, Machado-Vieira R, Park L, Merikangas KR, Zarate CA. Symptom Trajectories in the Months Before and After a Suicide Attempt in Individuals with Bipolar Disorder:A STEP-BD Study. Bipolar Disorders. PMID 31737973 DOI: 10.1111/Bdi.12873 |
0.335 |
|
| 2019 |
Kadriu B, Farmer CA, Yuan P, Park LT, Deng ZD, Moaddel R, Henter ID, Shovestul B, Ballard ED, Kraus C, Gold PW, Machado-Vieira R, Zarate CA. The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response. Molecular Psychiatry. PMID 31732715 DOI: 10.1038/S41380-019-0589-8 |
0.423 |
|
| 2019 |
Nugent AC, Ballard ED, Park LT, Zarate CA. Research on the pathophysiology, treatment, and prevention of suicide: practical and ethical issues. Bmc Psychiatry. 19: 332. PMID 31675949 DOI: 10.1186/S12888-019-2301-6 |
0.305 |
|
| 2019 |
Kraus C, Wasserman D, Henter ID, Acevedo-Diaz E, Kadriu B, Zarate CA. The influence of ketamine on drug discovery in depression. Drug Discovery Today. PMID 31382015 DOI: 10.1016/J.Drudis.2019.07.007 |
0.476 |
|
| 2019 |
Nugent AC, Farmer C, Evans JW, Snider SL, Banerjee D, Zarate CA. Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder. Human Brain Mapping. PMID 31179620 DOI: 10.1002/Hbm.24679 |
0.419 |
|
| 2019 |
Szczepanik JE, Reed JL, Nugent AC, Ballard ED, Evans JW, Lejuez CW, Zarate CA. Correction to: Mapping anticipatory anhedonia: an fMRI study. Brain Imaging and Behavior. PMID 31172359 DOI: 10.1007/S11682-019-00131-6 |
0.729 |
|
| 2019 |
Nolen WA, Licht RW, Young AH, Malhi GS, Tohen M, Vieta E, Kupka RW, Zarate C, Nielsen RE, Baldessarini R, Severus E. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disorders. PMID 31112628 DOI: 10.1111/Bdi.12805 |
0.316 |
|
| 2019 |
Szczepanik JE, Reed JL, Nugent AC, Ballard ED, Evans JW, Lejuez CW, Zarate CA. Mapping anticipatory anhedonia: an fMRI study. Brain Imaging and Behavior. PMID 31030316 DOI: 10.1007/S11682-019-00084-W |
0.791 |
|
| 2019 |
Ballard ED, Cui L, Vandeleur C, Castelao E, Zarate CA, Preisig M, Merikangas KR. Familial Aggregation and Coaggregation of Suicide Attempts and Comorbid Mental Disorders in Adults. Jama Psychiatry. PMID 30916728 DOI: 10.1001/Jamapsychiatry.2019.0248 |
0.304 |
|
| 2019 |
Zanos P, Highland JN, Stewart BW, Georgiou P, Jenne CE, Lovett J, Morris PJ, Thomas CJ, Moaddel R, Zarate CA, Gould TD. ()-hydroxynorketamine exerts mGlu receptor-dependent antidepressant actions. Proceedings of the National Academy of Sciences of the United States of America. PMID 30867285 DOI: 10.1073/Pnas.1819540116 |
0.38 |
|
| 2019 |
Reed JL, Nugent AC, Furey ML, Szczepanik JE, Evans JW, Zarate CA. Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 30826253 DOI: 10.1016/J.Bpsc.2019.01.005 |
0.807 |
|
| 2019 |
Lumsden EW, Troppoli TA, Myers SJ, Zanos P, Aracava Y, Kehr J, Lovett J, Kim S, Wang FH, Schmidt S, Jenne CE, Yuan P, Morris PJ, Thomas CJ, Zarate CA, et al. Antidepressant-relevant concentrations of the ketamine metabolite (2,6)-hydroxynorketamine do not block NMDA receptor function. Proceedings of the National Academy of Sciences of the United States of America. PMID 30796190 DOI: 10.1073/Pnas.1816071116 |
0.303 |
|
| 2019 |
Ballard ED, Reed JL, Szczepanik J, Evans JW, Yarrington JS, Dickstein DP, Nock MK, Nugent AC, Zarate CA. Functional Imaging of the Implicit Association of the Self With Life and Death. Suicide & Life-Threatening Behavior. PMID 30761601 DOI: 10.1111/Sltb.12543 |
0.75 |
|
| 2019 |
Park LT, Zarate CA. Depression in the Primary Care Setting. The New England Journal of Medicine. 380: 559-568. PMID 30726688 DOI: 10.1056/Nejmcp1712493 |
0.402 |
|
| 2019 |
Wilkinson ST, Farmer C, Ballard E, Mathew SJ, Grunebaum MF, Murrough JW, Sos P, Wang G, Gueorguieva R, Zarate CA. Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30653192 DOI: 10.1038/S41386-019-0317-8 |
0.301 |
|
| 2019 |
Ballard ED, Vande Voort JL, Bernert RA, Luckenbaugh DA, Richards EM, Niciu MJ, Furey ML, Duncan WC, Zarate CA. Correction. Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder The Journal of Clinical Psychiatry. 77: e1655. PMID 28086017 DOI: 10.4088/JCP.16lcx11319 |
0.335 |
|
| 2019 |
Mensah M, Song C, Akula N, Zarate C, Mickey B, McMahon FJ. T33DO RARE CODING VARIANTS PLAY A ROLE IN TREATMENT RESISTANT DEPRESSION? European Neuropsychopharmacology. 29: S234-S235. DOI: 10.1016/J.Euroneuro.2019.08.232 |
0.389 |
|
| 2019 |
Song C, Hou L, Akula N, Zarate C, Mickey B, McMahon F. Rare Coding Variants In Treatment-Resistant Depression European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.389 |
0.424 |
|
| 2019 |
Cavanaugh G, Greenstein D, Farmer C, Zarate C, Evans J. S127. Heart Rate Variability in Patients With Treatment-Resistant Depression and Healthy Controls After Treatment With Ketamine Biological Psychiatry. 85: S345-S346. DOI: 10.1016/J.Biopsych.2019.03.878 |
0.395 |
|
| 2019 |
Kadriu B, Yuan P, Moaddel R, Farmer C, Zarate C. S93. Ketamine Treatment Modulates the Kynurenine and Arginine Pathways in Depressed Unipolar and Bipolar Patients Biological Psychiatry. 85: S333. DOI: 10.1016/J.Biopsych.2019.03.844 |
0.473 |
|
| 2019 |
Fields J, Gilbert J, Ballard E, Waldman L, Zarate C. F125. Magnetoencephalography of the Suicide Implicit Association Task Biological Psychiatry. 85: S261-S262. DOI: 10.1016/J.Biopsych.2019.03.662 |
0.614 |
|
| 2019 |
Reed J, Evans J, Nugent A, Szczepanik J, Zarate C. F123. Comparison of fMRI Emotional Processing Tasks Used for Detecting Effects of Ketamine and Predicting Response in Depression Biological Psychiatry. 85: S261. DOI: 10.1016/J.Biopsych.2019.03.660 |
0.792 |
|
| 2019 |
Gilbert J, Nugent A, Zarate C. F118. Ketamine and Attentional Bias to Threat: Dynamic Causal Modeling of AMPA and NMDA Connectivity Estimates From Magnetoencephalography Biological Psychiatry. 85: S259. DOI: 10.1016/J.Biopsych.2019.03.655 |
0.598 |
|
| 2019 |
Kraus C, Zarate C, Evans J. F110. Replicating the Effects of Ketamine on Global Brain Connectivity in Treatment Resistant Depression Biological Psychiatry. 85: S255-S256. DOI: 10.1016/J.Biopsych.2019.03.647 |
0.416 |
|
| 2019 |
Mkrtchian A, Evans J, Farmer C, Greenstein D, Nugent A, Zarate C. F108. The Relationship Between the Habenula, Motivational Symptoms, and Ketamine Treatment Biological Psychiatry. 85: S255. DOI: 10.1016/J.Biopsych.2019.03.645 |
0.704 |
|
| 2018 |
Park L, Furey M, Nugent A, Farmer C, Ellis J, Szczepanik J, Lener M, Zarate C. RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine. Biological Psychiatry. 83: S305-S306. PMID 32005321 DOI: 10.1016/J.Biopsych.2018.02.787 |
0.367 |
|
| 2018 |
Guo W, Machado-Vieira R, Mathew S, Murrough JW, Charney DS, Gruenbaum M, Oquendo MA, Kadriu B, Akula N, Henter I, Yuan P, Merikangas K, Drevets W, Furey M, Mann JJ, ... ... Zarate CA, et al. Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression. Translational Psychiatry. 8: 280. PMID 30552317 DOI: 10.1038/S41398-018-0311-7 |
0.493 |
|
| 2018 |
Nugent AC, Wills KE, Gilbert JR, Zarate CA. Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study. Psychiatry Research. Neuroimaging. 283: 64-66. PMID 30551012 DOI: 10.1016/J.Pscychresns.2018.09.001 |
0.721 |
|
| 2018 |
Highland JN, Morris PJ, Zanos P, Lovett J, Ghosh S, Wang AQ, Zarate CA, Thomas CJ, Moaddel R, Gould TD. Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of ( 2R,6R)-hydroxynorketamine. Journal of Psychopharmacology (Oxford, England). 269881118812095. PMID 30488740 DOI: 10.1177/0269881118812095 |
0.331 |
|
| 2018 |
Kadriu B, Musazzi L, Henter ID, Graves M, Popoli M, Zarate CA. Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments. The International Journal of Neuropsychopharmacology. PMID 30445512 DOI: 10.1093/Ijnp/Pyy094 |
0.472 |
|
| 2018 |
Saligan LN, Farmer C, Ballard ED, Kadriu B, Zarate CA. Disentangling the association of depression on the anti-fatigue effects of ketamine. Journal of Affective Disorders. 244: 42-45. PMID 30312839 DOI: 10.1016/J.Jad.2018.10.089 |
0.458 |
|
| 2018 |
Gould TD, Zarate CA, Thompson SM. Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants. Annual Review of Pharmacology and Toxicology. PMID 30296896 DOI: 10.1146/Annurev-Pharmtox-010617-052811 |
0.442 |
|
| 2018 |
Park L, Furey M, Nugent AC, Farmer C, Ellis J, Szczepanik J, Lener MS, Zarate CA. Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder. The International Journal of Neuropsychopharmacology. PMID 30184133 DOI: 10.1093/Ijnp/Pyy051 |
0.505 |
|
| 2018 |
Moaddel R, Shardell M, Khadeer M, Lovett J, Kadriu B, Ravichandran S, Morris PJ, Yuan P, Thomas CJ, Gould TD, Ferrucci L, Zarate CA. Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects. Psychopharmacology. PMID 30116859 DOI: 10.1007/S00213-018-4992-7 |
0.48 |
|
| 2018 |
Sinyor M, Williams M, Belo S, Orser B, Vincent M, Mah L, Zarate C, Castel S, Levitt AJ, Schaffer A. Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting. Journal of Affective Disorders. 241: 103-109. PMID 30107350 DOI: 10.1016/J.Jad.2018.07.073 |
0.461 |
|
| 2018 |
Reed JL, Nugent AC, Furey ML, Szczepanik JE, Evans JW, Zarate CA. Ketamine normalizes brain activity during emotionally valenced attentional processing in depression. Neuroimage. Clinical. 20: 92-101. PMID 30094160 DOI: 10.1016/J.Nicl.2018.07.006 |
0.815 |
|
| 2018 |
Reed JL, Nugent AC, Furey ML, Szczepanik JE, Evans JW, Zarate CA. Ketamine normalizes brain activity during emotionally valenced attentional processing in depression. Neuroimage. Clinical. 20: 92-101. PMID 30094160 DOI: 10.1016/j.nicl.2018.07.006 |
0.38 |
|
| 2018 |
Richards EM, Zanotti-Fregonara P, Fujita M, Newman L, Farmer C, Ballard ED, Machado-Vieira R, Yuan P, Niciu MJ, Lyoo CH, Henter ID, Salvadore G, Drevets WC, Kolb H, Innis RB, ... Zarate CA, et al. PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects. Ejnmmi Research. 8: 57. PMID 29971587 DOI: 10.1186/S13550-018-0401-9 |
0.442 |
|
| 2018 |
Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate CA, Gould TD. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. Pharmacological Reviews. 70: 621-660. PMID 29945898 DOI: 10.1124/Pr.117.015198 |
0.313 |
|
| 2018 |
Evans JW, Lally N, An L, Li N, Nugent AC, Banerjee D, Snider SL, Shen J, Roiser JP, Zarate CA. 7T H-MRS in major depressive disorder: a Ketamine Treatment Study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29748628 DOI: 10.1038/S41386-018-0057-1 |
0.776 |
|
| 2018 |
Gilbert JR, Yarrington JS, Wills KE, Nugent AC, Zarate CA. Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling. The International Journal of Neuropsychopharmacology. PMID 29668918 DOI: 10.1093/Ijnp/Pyy041 |
0.736 |
|
| 2018 |
Evans JW, Szczepanik J, Brutsché N, Park LT, Nugent AC, Zarate CA. Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration. Biological Psychiatry. PMID 29580569 DOI: 10.1016/J.Biopsych.2018.01.027 |
0.448 |
|
| 2018 |
Zanos P, Thompson SM, Duman RS, Zarate CA, Gould TD. Convergent Mechanisms Underlying Rapid Antidepressant Action. Cns Drugs. PMID 29516301 DOI: 10.1007/S40263-018-0492-X |
0.429 |
|
| 2018 |
Niciu MJ, Shovestul BJ, Jaso BA, Farmer C, Luckenbaugh DA, Brutsche NE, Park LT, Ballard ED, Zarate CA. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression. Journal of Affective Disorders. 232: 310-315. PMID 29501990 DOI: 10.1016/J.Jad.2018.02.049 |
0.449 |
|
| 2018 |
Nugent AC, Ballard ED, Gould TD, Park LT, Moaddel R, Brutsche NE, Zarate CA. Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects. Molecular Psychiatry. PMID 29487402 DOI: 10.1038/S41380-018-0028-2 |
0.432 |
|
| 2018 |
Henter ID, de Sousa RT, Zarate CA. Glutamatergic Modulators in Depression. Harvard Review of Psychiatry. PMID 29465478 DOI: 10.1097/Hrp.0000000000000183 |
0.501 |
|
| 2018 |
Ballard ED, Yarrington JS, Farmer CA, Lener MS, Kadriu B, Lally N, Williams D, Machado-Vieira R, Niciu MJ, Park L, Zarate CA. Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales. Journal of Affective Disorders. 231: 51-57. PMID 29448238 DOI: 10.1016/J.Jad.2018.01.027 |
0.764 |
|
| 2018 |
Oppenheimer M, Falodun B, Hejazi N, Ballard E, Duncan WC, Zarate CA. S97. Insomnia is Associated With Response to Ketamine Administration in Patients With Major Depressive Disorder Biological Psychiatry. 83: S384-S385. DOI: 10.1016/J.Biopsych.2018.02.988 |
0.482 |
|
| 2018 |
Falodun T, Ballard E, Duncan WC, Hejazi N, Zarate C. S96. Wrist Actigraphy in Depressed Suicide Ideators and Non-Ideators Before and After Ketamine Biological Psychiatry. 83: S384. DOI: 10.1016/J.Biopsych.2018.02.987 |
0.454 |
|
| 2018 |
Shora L, Zarate C, Park L, Afanador MV. F170. Monoamine Oxidase Inhibitor Use in an Adult Patient With Treatment Resistant Depression Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.784 |
0.388 |
|
| 2018 |
Galiano C, Nugent A, Gilbert J, Ballard E, Zarate C. F147. Resting State Oscillatory Power and Risk of Suicide in Depressed Patients Biological Psychiatry. 83: S295. DOI: 10.1016/J.Biopsych.2018.02.761 |
0.68 |
|
| 2018 |
Gerlus N, Ballard E, Reed J, Nugent A, Szczepanik J, Zarate C. F145. Differences in Emotional Attention Biases Between Suicide Attempters and Depressed Non-Attempters Biological Psychiatry. 83: S294. DOI: 10.1016/J.Biopsych.2018.02.759 |
0.795 |
|
| 2018 |
Reed J, Nugent A, Furey M, Szczepanik J, Evans J, Zarate C. F136. Antidepressant Effects of Ketamine Versus Placebo are Differentially Associated With Brain Activity During Emotional Processing Biological Psychiatry. 83: S290-S291. DOI: 10.1016/J.Biopsych.2018.02.749 |
0.758 |
|
| 2018 |
Gilbert J, Galiano C, Nugent A, Zarate C. T139. Ketamine and Attentional Bias to Threat: MEG Correlates of Stimulus-Evoked Gamma-Band Response Biological Psychiatry. 83: S182. DOI: 10.1016/J.Biopsych.2018.02.476 |
0.584 |
|
| 2018 |
Glaus J, Cui L, Zarate C, Merikangas K. T116. Atypical Depression and Sleep Patterns Using a Family Study Approach Biological Psychiatry. 83: S173. DOI: 10.1016/J.Biopsych.2018.02.452 |
0.331 |
|
| 2018 |
Szczepanik J, Reed J, Nugent A, Zarate C, Ballard E. T114. Depressed Patients With History of Suicide Attempts Differ From Non-Attempters in Processing of Emotional Faces Biological Psychiatry. 83: S172-S173. DOI: 10.1016/J.Biopsych.2018.02.450 |
0.792 |
|
| 2017 |
Niciu MJ, Iadarola ND, Banerjee D, Luckenbaugh DA, Park M, Lener M, Park L, Ionescu DF, Ballard ED, Brutsche NE, Akula N, McMahon FJ, Machado-Vieira R, Nugent AC, Zarate CA. The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder. Journal of Psychopharmacology (Oxford, England). 269881117732514. PMID 29039254 DOI: 10.1177/0269881117732514 |
0.357 |
|
| 2017 |
Duncan WC, Ballard ED, Zarate CA. Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood. Handbook of Experimental Pharmacology. PMID 28939975 DOI: 10.1007/164_2017_51 |
0.368 |
|
| 2017 |
Zarate CA. What Should be Done When Elderly Patients with Major Depression Have Failed to Respond to All Treatments? The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 28939286 DOI: 10.1016/J.Jagp.2017.08.009 |
0.459 |
|
| 2017 |
Szczepanik JE, Furey ML, Nugent AC, Henter ID, Zarate CA, Lejuez CW. Altered interaction with environmental reinforcers in major depressive disorder: Relationship to anhedonia. Behaviour Research and Therapy. 97: 170-177. PMID 28806614 DOI: 10.1016/J.Brat.2017.08.003 |
0.377 |
|
| 2017 |
Ballard ED, Snider SL, Nugent AC, Luckenbaugh DA, Park L, Zarate CA. Active suicidal ideation during clinical antidepressant trials. Psychiatry Research. 257: 303-308. PMID 28787656 DOI: 10.1016/J.Psychres.2017.07.065 |
0.396 |
|
| 2017 |
Kadriu B, Gold PW, Luckenbaugh DA, Lener MS, Ballard ED, Niciu MJ, Henter ID, Park LT, De Sousa RT, Yuan P, Machado-Vieira R, Zarate CA. Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder. Molecular Psychiatry. PMID 28555075 DOI: 10.1038/Mp.2017.109 |
0.316 |
|
| 2017 |
Ballard ED, Wills K, Lally N, Richards EM, Luckenbaugh DA, Walls T, Ameli R, Niciu MJ, Brutsche NE, Park L, Zarate CA. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials. Journal of Affective Disorders. 218: 195-200. PMID 28477497 DOI: 10.1016/J.Jad.2017.04.057 |
0.738 |
|
| 2017 |
Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, Versace A, Bilderbeck AC, Uhlmann A, Mwangi B, Krämer B, Overs B, Hartberg CB, Abé C, Dima D, ... ... Zarate CA, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Molecular Psychiatry. PMID 28461699 DOI: 10.1038/Mp.2017.73 |
0.332 |
|
| 2017 |
Park LT, Lener MS, Hopkins M, Iadorola N, Machado-Vieira R, Ballard E, Nugent A, Zarate CA. A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression. Journal of Clinical Psychopharmacology. PMID 28338546 DOI: 10.1097/Jcp.0000000000000693 |
0.516 |
|
| 2017 |
Pennybaker SJ, Luckenbaugh DA, Park LT, Marquardt CA, Zarate CA. Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion. Biological Psychiatry. PMID 28262250 DOI: 10.1016/J.Biopsych.2016.08.041 |
0.369 |
|
| 2017 |
Lener MS, Kadriu B, Zarate CA. Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression. Drugs. PMID 28194724 DOI: 10.1007/S40265-017-0702-8 |
0.523 |
|
| 2017 |
Garay RP, Zarate CA, Charpeaud T, Citrome L, Correll CU, Hameg A, Llorca PM. Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Review of Neurotherapeutics. PMID 28092469 DOI: 10.1080/14737175.2017.1283217 |
0.412 |
|
| 2017 |
Zarate CA, Machado-Vieira R. Ketamine: translating mechanistic discoveries into the next generation of glutamate modulators for mood disorders. Molecular Psychiatry. PMID 28070122 DOI: 10.1038/Mp.2016.249 |
0.319 |
|
| 2017 |
Zarate C, Nugent A, Machado-Vieira R, Evans J, Reed J, Park L. 416. The KET-MOA Study: New Findings into the Neurobiology of the Response/non-Response, and Relapse Processes Biological Psychiatry. 81: S170. DOI: 10.1016/J.Biopsych.2017.02.900 |
0.741 |
|
| 2017 |
Szczepanik J, Reed J, Nugent A, Ballard E, Zarate C. 825. Mapping Anticipatory Anhedonia: An fMRI Study Biological Psychiatry. 81: S335. DOI: 10.1016/J.Biopsych.2017.02.892 |
0.731 |
|
| 2017 |
Zanos P, Moaddel R, Morris P, Georgiou P, Fischell J, Elmer G, Alkondon M, Yuan P, Pribut H, Singh N, Dossou K, Fang Y, Huang X, Mayo C, Wainer I, ... ... Zarate C, et al. 790. Ketamine Exerts NMDAR Inhibition-Independent Antidepressant Actions via Its Hydroxynorketamine Metabolites Biological Psychiatry. 81: S321. DOI: 10.1016/J.Biopsych.2017.02.857 |
0.319 |
|
| 2017 |
Kadriu B, Gold P, Lener M, Ballard E, Niciu M, Yuan P, Luckenbaugh D, Machado-Vieira R, Zarate C. 1003. Acute Ketamine Administration Corrects Abnormal Inflammatory Bone Markers in Major Depression Biological Psychiatry. 81: S405-S406. DOI: 10.1016/J.Biopsych.2017.02.730 |
0.38 |
|
| 2017 |
Hejazi N, Yu K, Park L, Duncan W, Zarate C. 861. Mood Dependent Effects of Ketamine on REM Eye Movements in Patients with Treatment Resistant Depression (TRD) Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.586 |
0.391 |
|
| 2017 |
Ballard E, Luckenbaugh D, Yarrington J, Lally N, Lener M, Machado-Vieira R, Kadriu B, Niciu M, Park L, Zarate C. 330. A Principal Components Analysis of Depression and Anhedonia Scales: Illustrating the Heterogeneity of Depression Biological Psychiatry. 81: S135. DOI: 10.1016/J.Biopsych.2017.02.345 |
0.755 |
|
| 2017 |
Airey M, Ballard E, Zarate C, Nugent A. 263. Beta Power in Magnetoencephalography as a Potential Neurobiological Marker for Risk of Suicide in Depressed Patients Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.277 |
0.392 |
|
| 2017 |
Reed J, Nugent A, Furey M, Szczepanik J, Evans J, Zarate C. 262. Ketamine’s Effects on Brain Function during Emotional Processing in Major Depressive Disorder Biological Psychiatry. 81: S108. DOI: 10.1016/J.Biopsych.2017.02.276 |
0.804 |
|
| 2017 |
Shovestul B, Jaso B, Luckenbaugh D, Park L, Niciu M, Zarate C. 199. Associations between Specific Dissociative Symptoms and Symptom Subsets and Anti-Depressant Response to Ketamine Biological Psychiatry. 81: S82-S83. DOI: 10.1016/J.Biopsych.2017.02.212 |
0.382 |
|
| 2017 |
Yu K, Park L, Luckenbaugh D, Pennybaker S, Hopkins M, Lener M, Zarate C. 517. Effects of Ketamine on Atypical and Typical Symptoms of Depression Biological Psychiatry. 81: S210. DOI: 10.1016/J.Biopsych.2017.02.1125 |
0.442 |
|
| 2016 |
Vande Voort JL, Ballard ED, Luckenbaugh DA, Bernert RA, Richards EM, Niciu MJ, Park LT, Machado-Vieira R, Duncan WC, Zarate CA. Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder. The Journal of Clinical Psychiatry. PMID 27929610 DOI: 10.4088/Jcp.15M10440 |
0.468 |
|
| 2016 |
Machado-Vieira R, Zanetti MV, Otaduy MC, De Sousa RT, Soeiro-de-Souza MG, Costa AC, Carvalho AF, Leite CC, Busatto GF, Zarate CA, Gattaz WF. Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study. Journal of Clinical Psychopharmacology. PMID 27902528 DOI: 10.1097/Jcp.0000000000000616 |
0.426 |
|
| 2016 |
Pennybaker SJ, Niciu MJ, Luckenbaugh DA, Zarate CA. Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion. Journal of Affective Disorders. PMID 27839782 DOI: 10.1016/J.Jad.2016.10.026 |
0.493 |
|
| 2016 |
Zanos P, Moaddel R, Morris PJ, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate CA, Gould TD. Reply to: Antidepressant Actions of Ketamine Versus Hydroxynorketamine. Biological Psychiatry. PMID 27817846 DOI: 10.1016/J.Biopsych.2016.08.039 |
0.357 |
|
| 2016 |
Tseng WL, Thomas LA, Harkins E, Stoddard J, Zarate CA, Pine DS, Leibenluft E, Brotman MA. Functional connectivity during masked and unmasked face emotion processing in bipolar disorder. Psychiatry Research. 258: 1-9. PMID 27814457 DOI: 10.1016/J.Pscychresns.2016.10.006 |
0.312 |
|
| 2016 |
Bernert RA, Luckenbaugh DA, Duncan WC, Iwata NG, Ballard ED, Zarate CA. Sleep architecture parameters as a putative biomarker of suicidal ideation in treatment-resistant depression. Journal of Affective Disorders. 208: 309-315. PMID 27810712 DOI: 10.1016/J.Jad.2016.08.050 |
0.358 |
|
| 2016 |
Henter ID, de Sousa RT, Gold PW, Brunoni AR, Zarate CA, Machado-Vieira R. Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression. Expert Review of Clinical Pharmacology. PMID 27781556 DOI: 10.1080/17512433.2017.1253472 |
0.393 |
|
| 2016 |
Fujita M, Richards EM, Niciu MJ, Ionescu DF, Zoghbi SS, Hong J, Telu S, Hines CS, Pike VW, Zarate CA, Innis RB. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor. Molecular Psychiatry. PMID 27725657 DOI: 10.1038/Mp.2016.171 |
0.443 |
|
| 2016 |
Park M, Newman LE, Gold PW, Luckenbaugh DA, Yuan P, Machado-Vieira R, Zarate CA. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression. Journal of Psychiatric Research. 84: 113-118. PMID 27718369 DOI: 10.1016/j.jpsychires.2016.09.025 |
0.327 |
|
| 2016 |
Berg HE, Ballard ED, Luckenbaugh DA, Nugent AC, Ionescu DF, Zarate CA. Recognition of emotional facial expressions in anxious and nonanxious depression. Comprehensive Psychiatry. 70: 1-8. PMID 27624417 DOI: 10.1016/J.Comppsych.2016.06.007 |
0.432 |
|
| 2016 |
Machado-Vieira R, Luckenbaugh DA, Ballard ED, Henter ID, Tohen M, Suppes T, Zarate CA. Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study. The American Journal of Psychiatry. appiajp201615091132. PMID 27523498 DOI: 10.1176/Appi.Ajp.2016.15091132 |
0.33 |
|
| 2016 |
Lamers F, Cui L, Hickie IB, Roca C, Machado-Vieira R, Zarate CA, Merikangas KR. Familial aggregation and heritability of the melancholic and atypical subtypes of depression. Journal of Affective Disorders. 204: 241-246. PMID 27450632 DOI: 10.1016/J.Jad.2016.06.040 |
0.405 |
|
| 2016 |
Lener MS, Niciu MJ, Ballard ED, Park M, Park LT, Nugent AC, Zarate CA. Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine. Biological Psychiatry. PMID 27449797 DOI: 10.1016/J.Biopsych.2016.05.005 |
0.389 |
|
| 2016 |
Szczepanik J, Nugent AC, Drevets WC, Khanna A, Zarate CA, Furey ML. Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder. Psychiatry Research. 254: 67-73. PMID 27366831 DOI: 10.1016/J.Pscychresns.2016.06.005 |
0.431 |
|
| 2016 |
Nugent AC, Robinson SE, Coppola R, Zarate CA. Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder. Psychiatry Research. 254: 56-66. PMID 27362845 DOI: 10.1016/J.Pscychresns.2016.06.006 |
0.415 |
|
| 2016 |
Ballard ED, Vande Voort JL, Bernert RA, Luckenbaugh DA, Richards EM, Niciu MJ, Furey ML, Duncan WC, Zarate CA. Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder. The Journal of Clinical Psychiatry. 77: 825-831. PMID 27337418 DOI: 10.4088/Jcp.15M09943 |
0.352 |
|
| 2016 |
Ballard ED, Vande Voort JL, Luckenbaugh DA, Machado-Vieira R, Tohen M, Zarate CA. Acute risk factors for suicide attempts and death: prospective findings from the STEP-BD study. Bipolar Disorders. PMID 27233466 DOI: 10.1111/Bdi.12397 |
0.344 |
|
| 2016 |
Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KS, Fang Y, Huang XP, Mayo CL, Wainer IW, ... ... Zarate CA, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature. PMID 27144355 DOI: 10.1038/Nature17998 |
0.375 |
|
| 2016 |
Machado-Vieira R, Gold PW, Luckenbaugh DA, Ballard ED, Richards EM, Henter ID, De Sousa RT, Niciu MJ, Yuan P, Zarate CA. The role of adipokines in the rapid antidepressant effects of ketamine. Molecular Psychiatry. PMID 27046644 DOI: 10.1038/Mp.2016.36 |
0.353 |
|
| 2016 |
Jaso BA, Niciu MJ, Iadarola ND, Lally N, Richards EM, Park M, Ballard ED, Nugent AC, Machado-Vieira R, Zarate CA. THERAPEUTIC MODULATION OF GLUTAMATE RECEPTORS IN MAJOR DEPRESSIVE DISORDER. Current Neuropharmacology. PMID 26997505 DOI: 10.2174/1570159X14666160321123221 |
0.693 |
|
| 2016 |
Nugent AC, Iadarola ND, Miller FG, Luckenbaugh DA, Zarate CA. Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health. The Lancet. Psychiatry. PMID 26971192 DOI: 10.1016/S2215-0366(16)00006-7 |
0.32 |
|
| 2016 |
Stoddard J, Gotts SJ, Brotman MA, Lever S, Hsu D, Zarate C, Ernst M, Pine DS, Leibenluft E. Aberrant intrinsic functional connectivity within and between corticostriatal and temporal-parietal networks in adults and youth with bipolar disorder. Psychological Medicine. 1-14. PMID 26924633 DOI: 10.1017/S0033291716000143 |
0.316 |
|
| 2016 |
Saligan LN, Luckenbaugh DA, Slonena EE, Machado-Vieira R, Zarate CA. An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder. Journal of Affective Disorders. 194: 115-119. PMID 26807672 DOI: 10.1016/J.Jad.2016.01.009 |
0.469 |
|
| 2016 |
Richards EM, Mathews DC, Luckenbaugh DA, Ionescu DF, Machado-Vieira R, Niciu MJ, Duncan WC, Nolan NM, Franco-Chaves JA, Hudzik T, Maciag C, Li S, Cross A, Smith MA, Zarate CA. A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression. Psychopharmacology. PMID 26728893 DOI: 10.1007/S00213-015-4195-4 |
0.434 |
|
| 2016 |
Park M, Niciu MJ, Zarate CA. Erratum to: Novel Glutamatergic Treatments for Severe Mood Disorders Current Behavioral Neuroscience Reports. 3: 86-86. DOI: 10.1007/S40473-016-0069-2 |
0.34 |
|
| 2015 |
Park M, Niciu MJ, Zarate CA. Novel Glutamatergic Treatments for Severe Mood Disorders. Current Behavioral Neuroscience Reports. 2: 198-208. PMID 26824031 DOI: 10.1007/S40473-015-0050-5 |
0.39 |
|
| 2015 |
Machado-Vieira R, Henter ID, Zarate CA. New Targets for Rapid Antidepressant Action. Progress in Neurobiology. PMID 26724279 DOI: 10.1016/J.Pneurobio.2015.12.001 |
0.351 |
|
| 2015 |
Zarate CA, Niciu MJ. Ketamine for depression: evidence, challenges and promise. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 348-50. PMID 26407791 DOI: 10.1002/Wps.20269 |
0.515 |
|
| 2015 |
de Sousa RT, Streck EL, Forlenza OV, Brunoni AR, Zanetti MV, Ferreira GK, Diniz BS, Portela LV, Carvalho AF, Zarate CA, Gattaz WF, Machado-Vieira R. Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder. Neuroscience Letters. 605: 65-8. PMID 26297865 DOI: 10.1016/J.Neulet.2015.08.022 |
0.382 |
|
| 2015 |
Zanos P, Piantadosi SC, Wu HQ, Pribut HJ, Dell MJ, Can A, Snodgrass HR, Zarate CA, Schwarcz R, Gould TD. The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition. The Journal of Pharmacology and Experimental Therapeutics. 355: 76-85. PMID 26265321 DOI: 10.1124/Jpet.115.225664 |
0.383 |
|
| 2015 |
Saligan LN, Luckenbaugh DA, Slonena EE, Machado-Vieira R, Zarate CA. Development of a clinician-administered National Institutes of Health-Brief Fatigue Inventory: A measure of fatigue in the context of depressive disorders. Journal of Psychiatric Research. 68: 99-105. PMID 26228407 DOI: 10.1016/J.Jpsychires.2015.06.012 |
0.48 |
|
| 2015 |
Ballard ED, Luckenbaugh DA, Richards EM, Walls TL, Brutsché NE, Ameli R, Niciu MJ, Vande Voort JL, Zarate CA. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant. Journal of Psychiatric Research. 68: 68-73. PMID 26228403 DOI: 10.1016/J.Jpsychires.2015.06.003 |
0.413 |
|
| 2015 |
Schaffer A, Isometsä ET, Tondo L, Moreno DH, Sinyor M, Kessing LV, Turecki G, Weizman A, Azorin JM, Ha K, Reis C, Cassidy F, Goldstein T, Rihmer Z, Beautrais A, ... ... Zarate CA, et al. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. The Australian and New Zealand Journal of Psychiatry. 49: 785-802. PMID 26185269 DOI: 10.1177/0004867415594427 |
0.349 |
|
| 2015 |
Schaffer A, Isometsä ET, Azorin JM, Cassidy F, Goldstein T, Rihmer Z, Sinyor M, Tondo L, Moreno DH, Turecki G, Reis C, Kessing LV, Ha K, Weizman A, Beautrais A, ... ... Zarate CA, et al. A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. The Australian and New Zealand Journal of Psychiatry. PMID 26175498 DOI: 10.1177/0004867415594428 |
0.343 |
|
| 2015 |
Xu AJ, Niciu MJ, Lundin NB, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Ballard ED, Brutsche NE, Machado-Vieira R, Zarate CA. Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression. Neural Plasticity. 2015: 858251. PMID 26137324 DOI: 10.1155/2015/858251 |
0.789 |
|
| 2015 |
Lally N, An L, Banerjee D, Niciu MJ, Luckenbaugh DA, Richards EM, Roiser JP, Shen J, Zarate CA, Nugent AC. Reliability of 7T (1) H-MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between- and within-sessions investigation. Journal of Magnetic Resonance Imaging : Jmri. PMID 26059603 DOI: 10.1002/Jmri.24970 |
0.733 |
|
| 2015 |
Zarate CA, Machado-Vieira R. Potential Pathways Involved in the Rapid Antidepressant Effects of Nitrous Oxide. Biological Psychiatry. 78: 2-4. PMID 26051637 DOI: 10.1016/J.Biopsych.2015.04.007 |
0.402 |
|
| 2015 |
Nugent AC, Robinson SE, Coppola R, Furey ML, Zarate CA. Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder. Neuroimage. 118: 1-12. PMID 26032890 DOI: 10.1016/J.Neuroimage.2015.05.051 |
0.369 |
|
| 2015 |
Iadarola ND, Niciu MJ, Richards EM, Vande Voort JL, Ballard ED, Lundin NB, Nugent AC, Machado-Vieira R, Zarate CA. Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. Therapeutic Advances in Chronic Disease. 6: 97-114. PMID 25954495 DOI: 10.1177/2040622315579059 |
0.786 |
|
| 2015 |
Furey ML, Drevets WC, Szczepanik J, Khanna A, Nugent A, Zarate CA. Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25820840 DOI: 10.1093/Ijnp/Pyv028 |
0.403 |
|
| 2015 |
Machado-Vieira R, Zanetti MV, Teixeira AL, Uno M, Valiengo LL, Soeiro-de-Souza MG, Oba-Shinjo SM, de Sousa RT, Zarate CA, Gattaz WF, Marie SK. Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 468-73. PMID 25726893 DOI: 10.1016/J.Euroneuro.2015.02.002 |
0.383 |
|
| 2015 |
Lally N, Nugent AC, Luckenbaugh DA, Niciu MJ, Roiser JP, Zarate CA. Neural correlates of change in major depressive disorder anhedonia following open-label ketamine. Journal of Psychopharmacology (Oxford, England). 29: 596-607. PMID 25691504 DOI: 10.1177/0269881114568041 |
0.813 |
|
| 2015 |
Ionescu DF, Nugent AC, Luckenbaugh DA, Niciu MJ, Richards EM, Zarate CA, Furey ML. Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography. Acta Neuropsychiatrica. 27: 143-52. PMID 25600154 DOI: 10.1017/Neu.2014.46 |
0.49 |
|
| 2015 |
Luckenbaugh DA, Ameli R, Brutsche NE, Zarate CA. Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales. Journal of Psychiatric Research. 61: 40-5. PMID 25592045 DOI: 10.1016/J.Jpsychires.2014.12.015 |
0.406 |
|
| 2015 |
Teixeira AL, de Souza RT, Zanetti MV, Brunoni AR, Busatto GF, Zarate CA, Gattaz WF, Machado-Vieira R. Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment. Human Psychopharmacology. 30: 52-6. PMID 25572309 DOI: 10.1002/Hup.2450 |
0.423 |
|
| 2015 |
Monteggia LM, Zarate C. Antidepressant actions of ketamine: from molecular mechanisms to clinical practice. Current Opinion in Neurobiology. 30: 139-43. PMID 25562451 DOI: 10.1016/J.Conb.2014.12.004 |
0.336 |
|
| 2015 |
Ballard ED, Lally N, Nugent AC, Furey ML, Luckenbaugh DA, Zarate CA. Neural correlates of suicidal ideation and its reduction in depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25550331 DOI: 10.1093/Ijnp/Pyu069 |
0.731 |
|
| 2015 |
Ortiz R, Ulrich H, Zarate CA, Machado-Vieira R. Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 57: 117-31. PMID 25445063 DOI: 10.1016/J.Pnpbp.2014.10.016 |
0.351 |
|
| 2015 |
Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Zarate CA. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression. Bipolar Disorders. 17: 438-43. PMID 25400146 DOI: 10.1111/Bdi.12277 |
0.51 |
|
| 2015 |
Schaffer A, Isometsä ET, Tondo L, H Moreno D, Turecki G, Reis C, Cassidy F, Sinyor M, Azorin JM, Kessing LV, Ha K, Goldstein T, Weizman A, Beautrais A, Chou YH, ... ... Zarate CA, et al. International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disorders. 17: 1-16. PMID 25329791 DOI: 10.1111/Bdi.12271 |
0.346 |
|
| 2015 |
Brunoni AR, Machado-Vieira R, Zarate CA, Vieira EL, Valiengo L, Benseñor IM, Lotufo PA, Gattaz WF, Teixeira AL. Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 56: 91-6. PMID 25172025 DOI: 10.1016/J.Pnpbp.2014.08.009 |
0.31 |
|
| 2015 |
Moaddel R, Luckenbaugh DA, Xie Y, Villaseñor A, Brutsche NE, Machado-Vieira R, Ramamoorthy A, Lorenzo MP, Garcia A, Bernier M, Torjman MC, Barbas C, Zarate CA, Wainer IW. D-serine plasma concentration is a potential biomarker of (R, S)-ketamine antidepressant response in subjects with treatment-resistant depression Psychopharmacology. 232: 399-409. PMID 25056852 DOI: 10.1007/S00213-014-3669-0 |
0.391 |
|
| 2015 |
Ballard ED, Lally N, Nugent AC, Furey ML, Luckenbaugh DA, Zarate CA. Neural correlates of suicidal ideation and its reduction in depression International Journal of Neuropsychopharmacology. 18. DOI: 10.1093/ijnp/pyu069 |
0.74 |
|
| 2015 |
Luckenbaugh DA, Ameli R, Brutsche NE, Zarate CA. Rating depression over brief time intervals with the Hamilton Depression Rating Scale: Standard vs. abbreviated scales Journal of Psychiatric Research. 61: 40-45. DOI: 10.1016/j.jpsychires.2014.12.015 |
0.302 |
|
| 2014 |
Niciu MJ, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Ballard ED, Brutsche NE, Furey ML, Zarate CA. Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25539512 DOI: 10.1093/Ijnp/Pyu039 |
0.416 |
|
| 2014 |
Ortiz R, Niciu MJ, Lukkahati N, Saligan LN, Nugent AC, Luckenbaugh DA, Machado-Vieira R, Zarate CA. Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression. Journal of Affective Disorders. 172: 307-311. PMID 25451430 DOI: 10.1016/J.Jad.2014.09.015 |
0.4 |
|
| 2014 |
Singh NS, Zarate CA, Moaddel R, Bernier M, Wainer IW. What is hydroxynorketamine and what can it bring to neurotherapeutics? Expert Review of Neurotherapeutics. 14: 1239-42. PMID 25331415 DOI: 10.1586/14737175.2014.971760 |
0.317 |
|
| 2014 |
Ionescu DF, Niciu MJ, Richards EM, Zarate CA. Pharmacologic treatment of dimensional anxious depression: a review. The Primary Care Companion For Cns Disorders. 16. PMID 25317369 DOI: 10.4088/Pcc.13R01621 |
0.449 |
|
| 2014 |
Lally N, Nugent AC, Luckenbaugh DA, Ameli R, Roiser JP, Zarate CA. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression. Translational Psychiatry. 4: e469. PMID 25313512 DOI: 10.1038/Tp.2014.105 |
0.823 |
|
| 2014 |
Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Slonena EE, Vande Voort JL, Brutsche NE, Zarate CA. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine. The Journal of Clinical Psychiatry. 75: e932-8. PMID 25295436 DOI: 10.4088/Jcp.14M09049 |
0.497 |
|
| 2014 |
Ballard ED, Ionescu DF, Vande Voort JL, Niciu MJ, Richards EM, Luckenbaugh DA, Brutsché NE, Ameli R, Furey ML, Zarate CA. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. Journal of Psychiatric Research. 58: 161-6. PMID 25169854 DOI: 10.1016/J.Jpsychires.2014.07.027 |
0.471 |
|
| 2014 |
Niciu MJ, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Ballard ED, Brutsche NE, Furey ML, Zarate CA. Riluzole likely lacks antidepressant efficacy in ketamine non-responders. Journal of Psychiatric Research. 58: 197-9. PMID 25139008 DOI: 10.1016/J.Jpsychires.2014.07.022 |
0.394 |
|
| 2014 |
Ameli R, Luckenbaugh DA, Gould NF, Holmes MK, Lally N, Ballard ED, Zarate CA. SHAPS-C: the Snaith-Hamilton pleasure scale modified for clinician administration. Peerj. 2: e429. PMID 25024906 DOI: 10.7717/Peerj.429 |
0.733 |
|
| 2014 |
Lundin NB, Niciu MJ, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Brutsche NE, Machado-Vieira R, Zarate CA. Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine. Pharmacopsychiatry. 47: 141-4. PMID 24955551 DOI: 10.1055/S-0034-1377042 |
0.779 |
|
| 2014 |
Niciu MJ, Luckenbaugh DA, Ionescu DF, Guevara S, Machado-Vieira R, Richards EM, Brutsche NE, Nolan NM, Zarate CA. Clinical predictors of ketamine response in treatment-resistant major depression. The Journal of Clinical Psychiatry. 75: e417-23. PMID 24922494 DOI: 10.4088/Jcp.13M08698 |
0.467 |
|
| 2014 |
de Sousa RT, Zanetti MV, Busatto GF, Mouro MG, Zarate CA, Gattaz WF, Higa EM, Machado-Vieira R. Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes. Journal of Psychiatric Research. 55: 96-100. PMID 24768108 DOI: 10.1016/J.Jpsychires.2014.03.023 |
0.382 |
|
| 2014 |
Ellis JS, Zarate CA, Luckenbaugh DA, Furey ML. Antidepressant treatment history as a predictor of response to scopolamine: Clinical implications Journal of Affective Disorders. 162: 39-42. PMID 24767003 DOI: 10.1016/J.Jad.2014.03.010 |
0.359 |
|
| 2014 |
Ballard ED, Ionescu DF, Vande Voort JL, Slonena EE, Franco-Chaves JA, Zarate CA, Grillon C. Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attempt. Journal of Affective Disorders. 162: 34-8. PMID 24767002 DOI: 10.1016/J.Jad.2014.03.027 |
0.405 |
|
| 2014 |
Brunoni AR, Machado-Vieira R, Zarate CA, Vieira EL, Vanderhasselt MA, Nitsche MA, Valiengo L, Benseñor IM, Lotufo PA, Gattaz WF, Teixeira AL. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1144-51. PMID 24702987 DOI: 10.1016/J.Euroneuro.2014.03.006 |
0.439 |
|
| 2014 |
Villaseñor A, Ramamoorthy A, Silva Dos Santos M, Lorenzo MP, Laje G, Zarate C, Barbas C, Wainer IW. A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: Evidence for a response-related difference in mitochondrial networks British Journal of Pharmacology. 171: 2230-2242. PMID 24684390 DOI: 10.1111/Bph.12494 |
0.441 |
|
| 2014 |
Luckenbaugh DA, Niciu MJ, Ionescu DF, Nolan NM, Richards EM, Brutsche NE, Guevara S, Zarate CA. Do the dissociative side effects of ketamine mediate its antidepressant effects? Journal of Affective Disorders. 159: 56-61. PMID 24679390 DOI: 10.1016/J.Jad.2014.02.017 |
0.44 |
|
| 2014 |
Suppes T, Frank E, DePaulo JR, Davis L, Zarate CA, Angst J, Fawcett J. Letter to the editor in response to 2012 article by Frances and Jones. Bipolar Disorders. 16: 214-5. PMID 24597757 DOI: 10.1111/Bdi.12176 |
0.358 |
|
| 2014 |
Niciu MJ, Henter ID, Luckenbaugh DA, Zarate CA, Charney DS. Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. Annual Review of Pharmacology and Toxicology. 54: 119-39. PMID 24392693 DOI: 10.1146/Annurev-Pharmtox-011613-135950 |
0.463 |
|
| 2014 |
de Sousa RT, Zarate CA, Zanetti MV, Costa AC, Talib LL, Gattaz WF, Machado-Vieira R. Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. Journal of Psychiatric Research. 50: 36-41. PMID 24332923 DOI: 10.1016/J.Jpsychires.2013.11.011 |
0.413 |
|
| 2014 |
Niciu MJ, Ionescu DF, Richards EM, Zarate CA. Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder. Journal of Neural Transmission (Vienna, Austria : 1996). 121: 907-24. PMID 24318540 DOI: 10.1007/S00702-013-1130-X |
0.467 |
|
| 2014 |
Brunoni AR, Machado-Vieira R, Zarate CA, Valiengo L, Vieira EL, Benseñor IM, Lotufo PA, Gattaz WF, Teixeira AL. Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial. Psychopharmacology. 231: 1315-23. PMID 24150249 DOI: 10.1007/S00213-013-3322-3 |
0.451 |
|
| 2014 |
Merikangas KR, Cui L, Heaton L, Nakamura E, Roca C, Ding J, Qin H, Guo W, Shugart YY, Yao-Shugart Y, Zarate C, Angst J. Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders. Molecular Psychiatry. 19: 214-9. PMID 24126930 DOI: 10.1038/Mp.2013.116 |
0.388 |
|
| 2014 |
Nugent AC, Diazgranados N, Carlson PJ, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Drevets WC, Zarate CA. Neural correlates of rapid antidepressant response to ketamine in bipolar disorder Bipolar Disorders. 16: 119-128. PMID 24103187 DOI: 10.1111/Bdi.12118 |
0.424 |
|
| 2014 |
Niciu MJ, Henter ID, Sanacora G, Zarate CA. Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 15: 2-16. PMID 24024876 DOI: 10.3109/15622975.2013.829585 |
0.415 |
|
| 2014 |
Machado-Vieira R, Soeiro-De-Souza MG, Richards EM, Teixeira AL, Zarate CA. Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 15: 84-95. PMID 23998912 DOI: 10.3109/15622975.2013.830775 |
0.326 |
|
| 2014 |
Brotman MA, Tseng WL, Olsavsky AK, Fromm SJ, Muhrer EJ, Rutenberg JG, Deveney CM, Adleman NE, Zarate CA, Pine DS, Leibenluft E. Fronto-limbic-striatal dysfunction in pediatric and adult patients with bipolar disorder: impact of face emotion and attentional demands. Psychological Medicine. 44: 1639-51. PMID 23930595 DOI: 10.1017/S003329171300202X |
0.3 |
|
| 2014 |
Lally N, Nugent AC, Luckenbaugh DA, Zarate CA. Anti-anhedonic effect of ketamine and its neural correlates in major depressive disorder F1000research. 5. DOI: 10.7490/F1000Research.1095572.1 |
0.748 |
|
| 2014 |
Merikangas KR, Cui L, Heaton L, Nakamura E, Roca C, Ding J, Qin H, Guo W, Yao-Shugart Y, Zarate C, Angst J. Erratum: Independence of familial transmission of mania and depression: Results of the NIMH family study of affective spectrum disorders (Molecular Psychiatry (2014) 19:(272) doi:10.1038/mp.2013.116) Molecular Psychiatry. 19. DOI: 10.1038/Mp.2013.181 |
0.381 |
|
| 2014 |
Ballard ED, Voort JV, Luckenbaugh DA, Richards EM, Ionescu DF, Niciu MJ, Brutsche NE, Ameli R, Zarate CA. Suicidal ideation in the context of ketamine infusion: Relationship with depression and anxiety symptom clusters Comprehensive Psychiatry. 55: e45. DOI: 10.1016/J.Comppsych.2014.08.002 |
0.43 |
|
| 2013 |
Mathews DC, Richards EM, Niciu MJ, Ionescu DF, Rasimas JJ, Zarate CA. NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER. Translational Neuroscience. 4. PMID 24294519 DOI: 10.2478/S13380-013-0120-7 |
0.35 |
|
| 2013 |
Savitz J, Nugent AC, Bellgowan PS, Wright N, Tinsley R, Zarate CA, Herscovitch P, Drevets WC. Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study. Neuroimage. Clinical. 2: 341-55. PMID 24179788 DOI: 10.1016/J.Nicl.2013.02.004 |
0.371 |
|
| 2013 |
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, ... ... Zarate CA, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. The American Journal of Psychiatry. 170: 1249-62. PMID 24030475 DOI: 10.1176/Appi.Ajp.2013.13020185 |
0.388 |
|
| 2013 |
Furey ML, Zarate CA. Pulsed intravenous administration of scopolamine produces rapid antidepressant effects and modest side effects Journal of Clinical Psychiatry. 74: 850-851. PMID 24021505 DOI: 10.4088/Jcp.13Ac08584 |
0.454 |
|
| 2013 |
Grillon C, Franco-Chaves JA, Mateus CF, Ionescu DF, Zarate CA. Major depression is not associated with blunting of aversive responses; evidence for enhanced anxious anticipation. Plos One. 8: e70969. PMID 23951057 DOI: 10.1371/Journal.Pone.0070969 |
0.429 |
|
| 2013 |
Duncan WC, Zarate CA. Ketamine, sleep, and depression: Current status and new questions Current Psychiatry Reports. 15. PMID 23949569 DOI: 10.1007/S11920-013-0394-Z |
0.397 |
|
| 2013 |
Nugent AC, Carlson PJ, Bain EE, Eckelman W, Herscovitch P, Manji H, Zarate CA, Drevets WC. Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression Journal of Psychopharmacology. 27: 894-902. PMID 23926239 DOI: 10.1177/0269881113499204 |
0.376 |
|
| 2013 |
Zarate C, Duman RS, Liu G, Sartori S, Quiroz J, Murck H. New paradigms for treatment-resistant depression. Annals of the New York Academy of Sciences. 1292: 21-31. PMID 23876043 DOI: 10.1111/Nyas.12223 |
0.512 |
|
| 2013 |
Nugent AC, Davis RM, Zarate CA, Drevets WC. Reduced thalamic volumes in major depressive disorder. Psychiatry Research. 213: 179-85. PMID 23850106 DOI: 10.1016/J.Pscychresns.2013.05.004 |
0.448 |
|
| 2013 |
Mathews DC, Zarate CA. Current status of ketamine and related compounds for depression. The Journal of Clinical Psychiatry. 74: 516-7. PMID 23759454 DOI: 10.4088/Jcp.13Ac08382 |
0.412 |
|
| 2013 |
Zarate CA. New insights into the neurobiology, diagnosis, and treatment of mood disorders Cns Spectrums. 18: 228-230. PMID 23692663 DOI: 10.1017/S1092852913000254 |
0.385 |
|
| 2013 |
Martinowich K, Jimenez DV, Zarate CA, Manji HK. Rapid antidepressant effects: moving right along. Molecular Psychiatry. 18: 856-63. PMID 23689537 DOI: 10.1038/Mp.2013.55 |
0.403 |
|
| 2013 |
Müller HK, Wegener G, Liebenberg N, Zarate CA, Popoli M, Elfving B. Ketamine regulates the presynaptic release machinery in the hippocampus Journal of Psychiatric Research. 47: 892-899. PMID 23548331 DOI: 10.1016/J.Jpsychires.2013.03.008 |
0.32 |
|
| 2013 |
Carlson PJ, Diazgranados N, Nugent AC, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Manji HK, Zarate CA, Drevets WC. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: A preliminary positron emission tomography study Biological Psychiatry. 73: 1213-1221. PMID 23540908 DOI: 10.1016/J.Biopsych.2013.02.008 |
0.438 |
|
| 2013 |
Franco-Chaves JA, Mateus CF, Luckenbaugh DA, Martinez PE, Mallinger AG, Zarate CA. Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study. Journal of Affective Disorders. 149: 319-25. PMID 23517885 DOI: 10.1016/J.Jad.2013.02.003 |
0.43 |
|
| 2013 |
Ionescu DF, Niciu MJ, Henter ID, Zarate CA. Defining anxious depression: a review of the literature. Cns Spectrums. 18: 252-60. PMID 23507190 DOI: 10.1017/S1092852913000114 |
0.485 |
|
| 2013 |
Ionescu DF, Niciu MJ, Mathews DC, Richards EM, Zarate CA. Neurobiology of anxious depression: a review. Depression and Anxiety. 30: 374-85. PMID 23495126 DOI: 10.1002/Da.22095 |
0.497 |
|
| 2013 |
Niciu MJ, Ionescu DF, Mathews DC, Richards EM, Zarate CA. Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder. Cns Spectrums. 18: 242-51. PMID 23472710 DOI: 10.1017/S1092852913000138 |
0.379 |
|
| 2013 |
Niciu MJ, Ionescu DF, Mathews DC, Richards EM, Zarate CA. Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder. Cns Spectrums. 18: 231-41. PMID 23462230 DOI: 10.1017/S1092852913000059 |
0.414 |
|
| 2013 |
Zarate CA, Mathews DC, Furey ML. Human biomarkers of rapid antidepressant effects Biological Psychiatry. 73: 1142-1155. PMID 23374639 DOI: 10.1016/J.Biopsych.2012.11.031 |
0.468 |
|
| 2013 |
Furey ML, Drevets WC, Hoffman EM, Frankel E, Speer AM, Zarate CA. Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder. Jama Psychiatry. 70: 280-90. PMID 23364679 DOI: 10.1001/2013.Jamapsychiatry.60 |
0.478 |
|
| 2013 |
Zarate CA, Mathews D, Ibrahim L, Chaves JF, Marquardt C, Ukoh I, Jolkovsky L, Brutsche NE, Smith MA, Luckenbaugh DA. A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression. Biological Psychiatry. 74: 257-64. PMID 23206319 DOI: 10.1016/J.Biopsych.2012.10.019 |
0.464 |
|
| 2013 |
Drevets WC, Zarate CA, Furey ML. Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: A review Biological Psychiatry. 73: 1156-1163. PMID 23200525 DOI: 10.1016/J.Biopsych.2012.09.031 |
0.489 |
|
| 2013 |
Soeiro-de-Souza MG, Salvadore G, Moreno RA, Otaduy MC, Chaim KT, Gattaz WF, Zarate CA, Machado-Vieira R. Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 468-75. PMID 23072837 DOI: 10.1038/Npp.2012.203 |
0.325 |
|
| 2013 |
Machado-Vieira R, Luckenbaugh DA, Soeiro-de-Souza MG, Marca G, Henter ID, Busnello JV, Gattaz WF, Zarate CA. Early improvement with lithium in classic mania and its association with later response. Journal of Affective Disorders. 144: 160-4. PMID 22906798 DOI: 10.1016/J.Jad.2012.05.039 |
0.338 |
|
| 2013 |
Duncan WC, Selter J, Brutsche N, Sarasso S, Zarate CA. Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder. Journal of Affective Disorders. 145: 115-9. PMID 22871531 DOI: 10.1016/J.Jad.2012.05.042 |
0.407 |
|
| 2013 |
Duncan WC, Sarasso S, Ferrarelli F, Selter J, Riedner BA, Hejazi NS, Yuan P, Brutsche N, Manji HK, Tononi G, Zarate CA. Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 301-11. PMID 22676966 DOI: 10.1017/S1461145712000545 |
0.393 |
|
| 2013 |
Nugent AC, Davis RM, Zarate CA, Drevets WC. Reduced thalamic volumes in major depressive disorder Psychiatry Research - Neuroimaging. 213: 179-185. DOI: 10.1016/j.pscychresns.2013.05.004 |
0.376 |
|
| 2012 |
de Sousa RT, Busnello JV, Forlenza OV, Zanetti MV, Soeiro-de-Souza MG, van de Bilt MT, Moreno RA, Zarate CA, Gattaz WF, Machado-Vieira R. Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania. Journal of Psychiatric Research. 46: 1564-8. PMID 23000368 DOI: 10.1016/J.Jpsychires.2012.08.011 |
0.34 |
|
| 2012 |
Kaddurah-Daouk R, Yuan P, Boyle SH, Matson W, Wang Z, Zeng ZB, Zhu H, Dougherty GG, Yao JK, Chen G, Guitart X, Carlson PJ, Neumeister A, Zarate C, Krishnan RR, et al. Cerebrospinal fluid metabolome in mood disorders-remission state has a unique metabolic profile. Scientific Reports. 2: 667. PMID 22993692 DOI: 10.1038/Srep00667 |
0.435 |
|
| 2012 |
Luckenbaugh DA, Ibrahim L, Brutsche N, Franco-Chaves J, Mathews D, Marquardt CA, Cassarly C, Zarate CA. Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression. Bipolar Disorders. 14: 880-7. PMID 22978511 DOI: 10.1111/Bdi.12003 |
0.461 |
|
| 2012 |
Zanotti-Fregonara P, Hines CS, Zoghbi SS, Liow JS, Zhang Y, Pike VW, Drevets WC, Mallinger AG, Zarate CA, Fujita M, Innis RB. Population-based input function and image-derived input function for [¹¹C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorder. Neuroimage. 63: 1532-41. PMID 22906792 DOI: 10.1016/J.Neuroimage.2012.08.007 |
0.308 |
|
| 2012 |
Laje G, Lally N, Mathews D, Brutsche N, Chemerinski A, Akula N, Kelmendi B, Simen A, McMahon FJ, Sanacora G, Zarate C. Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients. Biological Psychiatry. 72: e27-8. PMID 22771240 DOI: 10.1016/J.Biopsych.2012.05.031 |
0.742 |
|
| 2012 |
Mathews DC, Henter ID, Zarate CA. Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date. Drugs. 72: 1313-33. PMID 22731961 DOI: 10.2165/11633130-000000000-00000 |
0.358 |
|
| 2012 |
Ibrahim L, Diaz Granados N, Jolkovsky L, Brutsche N, Luckenbaugh DA, Herring WJ, Potter WZ, Zarate CA. A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder. Journal of Clinical Psychopharmacology. 32: 551-7. PMID 22722512 DOI: 10.1097/Jcp.0B013E31825D70D6 |
0.473 |
|
| 2012 |
Turner AD, Furey ML, Drevets WC, Zarate C, Nugent AC. Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls. Neuropsychologia. 50: 2348-55. PMID 22714007 DOI: 10.1016/J.Neuropsychologia.2012.06.003 |
0.428 |
|
| 2012 |
Aan Het Rot M, Zarate CA, Charney DS, Mathew SJ. Ketamine for depression: where do we go from here? Biological Psychiatry. 72: 537-47. PMID 22705040 DOI: 10.1016/J.Biopsych.2012.05.003 |
0.43 |
|
| 2012 |
Fujita M, Hines CS, Zoghbi SS, Mallinger AG, Dickstein LP, Liow JS, Zhang Y, Pike VW, Drevets WC, Innis RB, Zarate CA. Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorder. Biological Psychiatry. 72: 548-54. PMID 22677471 DOI: 10.1016/J.Biopsych.2012.04.030 |
0.413 |
|
| 2012 |
Weathers JD, Stringaris A, Deveney CM, Brotman MA, Zarate CA, Connolly ME, Fromm SJ, LeBourdais SB, Pine DS, Leibenluft E. A developmental study of the neural circuitry mediating motor inhibition in bipolar disorder. The American Journal of Psychiatry. 169: 633-41. PMID 22581312 DOI: 10.1176/Appi.Ajp.2012.11081244 |
0.322 |
|
| 2012 |
Kim P, Thomas LA, Rosen BH, Moscicki AM, Brotman MA, Zarate CA, Blair RJ, Pine DS, Leibenluft E. Differing amygdala responses to facial expressions in children and adults with bipolar disorder. The American Journal of Psychiatry. 169: 642-9. PMID 22535257 DOI: 10.1176/Appi.Ajp.2012.11081245 |
0.302 |
|
| 2012 |
Cornwell BR, Salvadore G, Furey M, Marquardt CA, Brutsche NE, Grillon C, Zarate CA. Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression. Biological Psychiatry. 72: 555-61. PMID 22521148 DOI: 10.1016/J.Biopsych.2012.03.029 |
0.483 |
|
| 2012 |
Zarate CA, Brutsche N, Laje G, Luckenbaugh DA, Venkata SL, Ramamoorthy A, Moaddel R, Wainer IW. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biological Psychiatry. 72: 331-8. PMID 22516044 DOI: 10.1016/J.Biopsych.2012.03.004 |
0.501 |
|
| 2012 |
Furey ML, Nugent AC, Speer AM, Luckenbaugh DA, Hoffman EM, Frankel E, Drevets WC, Zarate CA. Baseline mood-state measures as predictors of antidepressant response to scopolamine. Psychiatry Research. 196: 62-7. PMID 22349648 DOI: 10.1016/J.Psychres.2012.01.003 |
0.455 |
|
| 2012 |
Ibrahim L, Diazgranados N, Franco-Chaves J, Brutsche N, Henter ID, Kronstein P, Moaddel R, Wainer I, Luckenbaugh DA, Manji HK, Zarate CA. Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1526-33. PMID 22298121 DOI: 10.1038/Npp.2011.338 |
0.451 |
|
| 2012 |
Zarate CA, Brutsche NE, Ibrahim L, Franco-Chaves J, Diazgranados N, Cravchik A, Selter J, Marquardt CA, Liberty V, Luckenbaugh DA. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biological Psychiatry. 71: 939-46. PMID 22297150 DOI: 10.1016/J.Biopsych.2011.12.010 |
0.509 |
|
| 2012 |
Zhao X, Venkata SL, Moaddel R, Luckenbaugh DA, Brutsche NE, Ibrahim L, Zarate CA, Mager DE, Wainer IW. Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression. British Journal of Clinical Pharmacology. 74: 304-14. PMID 22295895 DOI: 10.1111/J.1365-2125.2012.04198.X |
0.416 |
|
| 2012 |
Salvadore G, van der Veen JW, Zhang Y, Marenco S, Machado-Vieira R, Baumann J, Ibrahim LA, Luckenbaugh DA, Shen J, Drevets WC, Zarate CA. An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1063-72. PMID 22040773 DOI: 10.1017/S1461145711001593 |
0.43 |
|
| 2012 |
Machado-Vieira R, Ibrahim L, Henter ID, Zarate CA. Novel glutamatergic agents for major depressive disorder and bipolar disorder. Pharmacology, Biochemistry, and Behavior. 100: 678-87. PMID 21971560 DOI: 10.1016/J.Pbb.2011.09.010 |
0.42 |
|
| 2012 |
Malkesman O, Austin DR, Tragon T, Wang G, Rompala G, Hamidi AB, Cui Z, Young WS, Nakazawa K, Zarate CA, Manji HK, Chen G. Acute D-serine treatment produces antidepressant-like effects in rodents. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1135-48. PMID 21906419 DOI: 10.1017/S1461145711001386 |
0.403 |
|
| 2012 |
Zarate C, Furey M, Duncan W, Cornwell B, Sarasso S, Tononi G. S.04.01 Plasticity based therapeutics for the treatment of mood disorders European Neuropsychopharmacology. 22: S81-S82. DOI: 10.1016/S0924-977X(12)70086-X |
0.335 |
|
| 2011 |
Manji HK, Henter ID, Zarate CA. Bipolar disorder: a neurobiological synthesis. Current Topics in Behavioral Neurosciences. 5: 331-40. PMID 25236563 DOI: 10.1007/7854_2010_98 |
0.333 |
|
| 2011 |
Machado-Vieira R, Manji HK, Zarate CA. Potential novel therapeutics for bipolar disorders. Current Topics in Behavioral Neurosciences. 5: 303-29. PMID 25236562 DOI: 10.1007/7854_2010_51 |
0.347 |
|
| 2011 |
Kupfer DJ, Angst J, Berk M, Dickerson F, Frangou S, Frank E, Goldstein BI, Harvey A, Laghrissi-Thode F, Leboyer M, Ostacher MJ, Sibille E, Strakowski SM, Suppes T, Tohen M, ... ... Zarate CA, et al. Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder. Annals of the New York Academy of Sciences. 1242: 1-25. PMID 22191553 DOI: 10.1111/J.1749-6632.2011.06336.X |
0.328 |
|
| 2011 |
Javitt DC, Schoepp D, Kalivas PW, Volkow ND, Zarate C, Merchant K, Bear MF, Umbricht D, Hajos M, Potter WZ, Lee CM. Translating glutamate: from pathophysiology to treatment. Science Translational Medicine. 3: 102mr2. PMID 21957170 DOI: 10.1126/Scitranslmed.3002804 |
0.37 |
|
| 2011 |
Ibrahim L, Duncan W, Luckenbaugh DA, Yuan P, Machado-Vieira R, Zarate CA. Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study. Brain Research Bulletin. 86: 129-33. PMID 21704134 DOI: 10.1016/J.Brainresbull.2011.06.003 |
0.41 |
|
| 2011 |
Ibrahim L, Diazgranados N, Luckenbaugh DA, Machado-Vieira R, Baumann J, Mallinger AG, Zarate CA. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 1155-9. PMID 21466832 DOI: 10.1016/J.Pnpbp.2011.03.019 |
0.499 |
|
| 2011 |
Savitz JB, Nugent AC, Bogers W, Roiser JP, Bain EE, Neumeister A, Zarate CA, Manji HK, Cannon DM, Marrett S, Henn F, Charney DS, Drevets WC. Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study. Biological Psychiatry. 69: 336-43. PMID 21094939 DOI: 10.1016/J.Biopsych.2010.09.027 |
0.672 |
|
| 2011 |
Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R, Cannon DM, Neumeister A, Zarate CA, Drevets WC. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage. 54: 2643-51. PMID 21073959 DOI: 10.1016/J.Neuroimage.2010.11.011 |
0.456 |
|
| 2011 |
Mah L, Zarate CA, Nugent AC, Singh JB, Manji HK, Drevets WC. Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression International Journal of Neuropsychopharmacology. 14: 545-551. PMID 21029512 DOI: 10.1017/S1461145710001203 |
0.468 |
|
| 2011 |
Machado-Vieira R, Ibrahim L, Zarate CA. Histone Deacetylases and Mood Disorders: Epigenetic Programming in Gene-Environment Interactions Cns Neuroscience and Therapeutics. 17: 699-704. PMID 20961400 DOI: 10.1111/J.1755-5949.2010.00203.X |
0.342 |
|
| 2011 |
Zarate C, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G. Glutamatergic modulators: the future of treating mood disorders? Harvard Review of Psychiatry. 18: 293-303. PMID 20825266 DOI: 10.3109/10673229.2010.511059 |
0.425 |
|
| 2010 |
Machado-Vieira R, Baumann J, Wheeler-Castillo C, Latov D, Henter ID, Salvadore G, Zarate CA. The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments. Pharmaceuticals (Basel, Switzerland). 3: 19-41. PMID 27713241 DOI: 10.3390/Ph3010019 |
0.468 |
|
| 2010 |
Salvadore G, Zarate CA. Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: A pathway to diagnosis, novel therapeutics, and personalized medicine? Biological Psychiatry. 68: 780-782. PMID 20946973 DOI: 10.1016/J.Biopsych.2010.09.011 |
0.337 |
|
| 2010 |
Fitzgerald PJ, Barkus C, Feyder M, Wiedholz LM, Chen YC, Karlsson RM, Machado-Vieira R, Graybeal C, Sharp T, Zarate C, Harvey-White J, Du J, Sprengel R, Gass P, Bannerman D, et al. Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? Neurobiology of Disease. 40: 608-21. PMID 20699120 DOI: 10.1016/J.Nbd.2010.08.005 |
0.346 |
|
| 2010 |
Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression Archives of General Psychiatry. 67: 793-802. PMID 20679587 DOI: 10.1001/Archgenpsychiatry.2010.90 |
0.463 |
|
| 2010 |
DiazGranados N, Ibrahim LA, Brutsche NE, Ameli R, Henter ID, Luckenbaugh DA, Machado-Vieira R, Zarate CA. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder Journal of Clinical Psychiatry. 71: 1605-1611. PMID 20673547 DOI: 10.4088/Jcp.09M05327Blu |
0.463 |
|
| 2010 |
Schaefer KL, Baumann J, Rich BA, Luckenbaugh DA, Zarate CA. Perception of facial emotion in adults with bipolar or unipolar depression and controls. Journal of Psychiatric Research. 44: 1229-35. PMID 20510425 DOI: 10.1016/J.Jpsychires.2010.04.024 |
0.456 |
|
| 2010 |
Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, Zarate CA. The neurobiology of the switch process in bipolar disorder: A review Journal of Clinical Psychiatry. 71: 1488-1501. PMID 20492846 DOI: 10.4088/Jcp.09R05259Gre |
0.37 |
|
| 2010 |
Quiroz JA, MacHado-Vieira R, Zarate CA, Manji HK. Novel insights into lithium's mechanism of action: Neurotrophic and neuroprotective effects Neuropsychobiology. 62: 50-60. PMID 20453535 DOI: 10.1159/000314310 |
0.303 |
|
| 2010 |
Cornwell BR, Salvadore G, Colon-Rosario V, Latov DR, Holroyd T, Carver FW, Coppola R, Manji HK, Zarate CA, Grillon C. Abnormal hippocampal functioning and impaired spatial navigation in depressed individuals: evidence from whole-head magnetoencephalography. The American Journal of Psychiatry. 167: 836-44. PMID 20439387 DOI: 10.1176/Appi.Ajp.2009.09050614 |
0.462 |
|
| 2010 |
Machado-Vieira R, Salvadore G, DiazGranados N, Ibrahim L, Latov D, Wheeler-Castillo C, Baumann J, Henter ID, Zarate CA. New therapeutic targets for mood disorders. Thescientificworldjournal. 10: 713-26. PMID 20419280 DOI: 10.1100/Tsw.2010.65 |
0.389 |
|
| 2010 |
Salvadore G, Cornwell BR, Sambataro F, Latov D, Colon-Rosario V, Carver F, Holroyd T, DiazGranados N, Machado-Vieira R, Grillon C, Drevets WC, Zarate CA. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1415-22. PMID 20393460 DOI: 10.1038/Npp.2010.24 |
0.35 |
|
| 2010 |
Salvadore G, Viale CI, Luckenbaugh DA, Zanatto VC, Portela LV, Souza DO, Zarate CA, Machado-Vieira R. Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34: 819-821. PMID 20206224 DOI: 10.1016/J.Pnpbp.2010.02.027 |
0.352 |
|
| 2010 |
Tamayo JM, Zarate CA, Vieta E, Vazquez G, Tohen M. Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar i disorder phases: A systematic review and meta-analysis International Journal of Neuropsychopharmacology. 13: 813-832. PMID 20128953 DOI: 10.1017/S1461145709991246 |
0.433 |
|
| 2010 |
Savitz J, Nugent AC, Bogers W, Liu A, Sills R, Luckenbaugh DA, Bain EE, Price JL, Zarate C, Manji HK, Cannon DM, Marrett S, Charney DS, Drevets WC. Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication. Neuroimage. 49: 2966-76. PMID 19931399 DOI: 10.1016/J.Neuroimage.2009.11.025 |
0.322 |
|
| 2010 |
Fujita M, Mallinger AG, Zarate CA, Dickstein LP, Zoghbi SS, Pike VW, Zhang Y, Innis RB, Drevets WC. Changes of brain phosphodiesterase 4 in major depression Neuroimage. 52: S51. DOI: 10.1016/J.Neuroimage.2010.04.232 |
0.429 |
|
| 2009 |
Machado-Vieira R, Yuan P, Brutsche N, DiazGranados N, Luckenbaugh D, Manji HK, Zarate CA. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist Journal of Clinical Psychiatry. 70: 1662-1666. PMID 19744406 DOI: 10.4088/Jcp.08M04659 |
0.358 |
|
| 2009 |
Tamayo JM, Sutton VK, Mattei MA, Diaz B, Jamal HH, Vieta E, Zarate CA, Fumero I, Tohen M. Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico. Journal of Clinical Psychopharmacology. 29: 358-61. PMID 19593175 DOI: 10.1097/Jcp.0B013E3181Ad223F |
0.398 |
|
| 2009 |
Zarate CA, Manji HK. Protein kinase C inhibitors: Rationale for use and potential in the treatment of bipolar disorder Cns Drugs. 23: 569-582. PMID 19552485 DOI: 10.2165/00023210-200923070-00003 |
0.343 |
|
| 2009 |
Machado-Vieira R, Manji HK, Zarate CA. The role of lithium in the treatment of bipolar disorder: Convergent evidence for neurotrophic effects as a unifying hypothesis Bipolar Disorders. 11: 92-109. PMID 19538689 DOI: 10.1111/J.1399-5618.2009.00714.X |
0.363 |
|
| 2009 |
MacHado-Vieira R, Manji HK, Zarate CA. The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders Neuroscientist. 15: 525-539. PMID 19471044 DOI: 10.1177/1073858409336093 |
0.363 |
|
| 2009 |
Machado-Vieira R, Salvadore G, Ibrahim LA, Diaz-Granados N, Zarate CA. Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders Current Pharmaceutical Design. 15: 1595-1611. PMID 19442176 DOI: 10.2174/138161209788168010 |
0.404 |
|
| 2009 |
Machado-Vieira R, Salvadore G, DiazGranados N, Zarate CA. Ketamine and the next generation of antidepressants with a rapid onset of action Pharmacology and Therapeutics. 123: 143-150. PMID 19397926 DOI: 10.1016/J.Pharmthera.2009.02.010 |
0.463 |
|
| 2009 |
Roiser JP, Cannon DM, Gandhi SK, Taylor Tavares J, Erickson K, Wood S, Klaver JM, Clark L, Zarate CA, Sahakian BJ, Drevets WC. Hot and cold cognition in unmedicated depressed subjects with bipolar disorder. Bipolar Disorders. 11: 178-89. PMID 19267700 DOI: 10.1111/J.1399-5618.2009.00669.X |
0.63 |
|
| 2009 |
Salvadore G, Cornwell BR, Colon-Rosario V, Coppola R, Grillon C, Zarate CA, Manji HK. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biological Psychiatry. 65: 289-95. PMID 18822408 DOI: 10.1016/J.Biopsych.2008.08.014 |
0.446 |
|
| 2008 |
Salvadore G, Drevets WC, Henter ID, Zarate CA, Manji HK. Early intervention in bipolar disorder, part II: therapeutics. Early Intervention in Psychiatry. 2: 136-46. PMID 19649153 DOI: 10.1111/J.1751-7893.2008.00072.X |
0.345 |
|
| 2008 |
Salvadore G, Drevets WC, Henter ID, Zarate CA, Manji HK. Early intervention in bipolar disorder, part I: clinical and imaging findings. Early Intervention in Psychiatry. 2: 122-35. PMID 19649152 DOI: 10.1111/J.1751-7893.2008.00071.X |
0.335 |
|
| 2008 |
Holmes MK, Erickson K, Luckenbaugh DA, Drevets WC, Bain EE, Cannon DM, Snow J, Sahakian BJ, Manji HK, Zarate CA. A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression. Bipolar Disorders. 10: 806-15. PMID 19032712 DOI: 10.1111/J.1399-5618.2008.00628.X |
0.393 |
|
| 2008 |
DiazGranados N, Zarate CA. A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder Current Psychiatry Reports. 10: 510-519. PMID 18980735 DOI: 10.1007/S11920-008-0081-7 |
0.311 |
|
| 2008 |
Zarate CA, Manji HK. Riluzole in psychiatry: a systematic review of the literature. Expert Opinion On Drug Metabolism & Toxicology. 4: 1223-34. PMID 18721116 DOI: 10.1517/17425255.4.9.1223 |
0.353 |
|
| 2008 |
Zarate CA, Manji HK. Bipolar disorder: candidate drug targets. The Mount Sinai Journal of Medicine, New York. 75: 226-47. PMID 18704977 DOI: 10.1002/Msj.20042 |
0.333 |
|
| 2008 |
Nowakowska C, Sachs GS, Zarate CA, Marangell LB, Calabrese JR, Goldberg JF, Ketter TA. Increased rate of non-right-handedness in patients with bipolar disorder. The Journal of Clinical Psychiatry. 69: 866-7. PMID 18681768 DOI: 10.4088/Jcp.V69N0522G |
0.329 |
|
| 2008 |
Machado-Vieira R, Soares JC, Lara DR, Luckenbaugh DA, Busnello JV, Marca G, Cunha A, Souza DO, Zarate CA, Kapczinski F. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania. The Journal of Clinical Psychiatry. 69: 1237-45. PMID 18681754 DOI: 10.4088/Jcp.V69N0806 |
0.333 |
|
| 2008 |
Machado-Vieira R, Salvadore G, Luckenbaugh DA, Manji HK, Zarate CA. Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. The Journal of Clinical Psychiatry. 69: 946-58. PMID 18435563 DOI: 10.4088/Jcp.V69N0610 |
0.495 |
|
| 2008 |
Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nature Reviews. Drug Discovery. 7: 426-37. PMID 18425072 DOI: 10.1038/Nrd2462 |
0.347 |
|
| 2008 |
Maeng S, Zarate CA. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Current Psychiatry Reports. 9: 467-74. PMID 18221626 DOI: 10.1007/S11920-007-0063-1 |
0.452 |
|
| 2008 |
Newberg AR, Catapano LA, Zarate CA, Manji HK. Neurobiology of bipolar disorder. Expert Review of Neurotherapeutics. 8: 93-110. PMID 18088203 DOI: 10.1586/14737175.8.1.93 |
0.354 |
|
| 2008 |
Maeng S, Zarate CA, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biological Psychiatry. 63: 349-52. PMID 17643398 DOI: 10.1016/J.Biopsych.2007.05.028 |
0.405 |
|
| 2007 |
Angst J, Gamma A, Gerber-Werder R, Zarate CA, Manji HK. Does long-term medication with lithium, clozapine or antidepressants prevent or attenuate dementia in bipolar and depressed patients? International Journal of Psychiatry in Clinical Practice. 11: 2-8. PMID 24941269 DOI: 10.1080/13651500600810133 |
0.366 |
|
| 2007 |
Gould NF, Holmes MK, Fantie BD, Luckenbaugh DA, Pine DS, Gould TD, Burgess N, Manji HK, Zarate CA. Performance on a virtual reality spatial memory navigation task in depressed patients. The American Journal of Psychiatry. 164: 516-9. PMID 17329478 DOI: 10.1176/Ajp.2007.164.3.516 |
0.395 |
|
| 2007 |
Singh JB, Zarate CA. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled trials. Bipolar Disorders. 8: 696-709. PMID 17156156 DOI: 10.1111/J.1399-5618.2006.00371.X |
0.341 |
|
| 2007 |
Du J, Suzuki K, Wei Y, Wang Y, Blumenthal R, Chen Z, Falke C, Zarate CA, Manji HK. The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 793-802. PMID 16936714 DOI: 10.1038/Sj.Npp.1301178 |
0.356 |
|
| 2007 |
Zarate CA, Charney DS, Manji HK. Searching for rational anti-N-methyl-D-aspartate treatment for depression: Reply [6] Archives of General Psychiatry. 64: 1100-1101. DOI: 10.1001/Archpsyc.64.9.1100 |
0.399 |
|
| 2006 |
Machado-Vieira R, Zarate CA, Manji HK. Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades. Current Psychosis & Therapeutics Reports. 4: 181-190. PMID 25620894 DOI: 10.1007/Bf02629394 |
0.419 |
|
| 2006 |
Du J, Machado-Vieira R, Maeng S, Martinowich K, Manji HK, Zarate CA. Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action. Drug Discovery Today. Therapeutic Strategies. 3: 519-526. PMID 25411578 DOI: 10.1016/J.Ddstr.2006.11.012 |
0.317 |
|
| 2006 |
Perlis RH, Baker RW, Zarate CA, Brown EB, Schuh LM, Jamal HH, Tohen M. Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial. The Journal of Clinical Psychiatry. 67: 1747-53. PMID 17196055 DOI: 10.4088/Jcp.V67N1112 |
0.327 |
|
| 2006 |
Mah L, Zarate CA, Singh J, Duan YF, Luckenbaugh DA, Manji HK, Drevets WC. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biological Psychiatry. 61: 765-75. PMID 17027930 DOI: 10.1016/J.Biopsych.2006.06.009 |
0.456 |
|
| 2006 |
Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry. 63: 856-64. PMID 16894061 DOI: 10.1001/Archpsyc.63.8.856 |
0.481 |
|
| 2006 |
Carlson PJ, Singh JB, Zarate CA, Drevets WC, Manji HK. Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 22-41. PMID 16490411 DOI: 10.1016/J.Nurx.2005.12.009 |
0.387 |
|
| 2006 |
Zarate CA, Singh J, Manji HK. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biological Psychiatry. 59: 1006-20. PMID 16487491 DOI: 10.1016/J.Biopsych.2005.10.021 |
0.372 |
|
| 2006 |
Zarate CA, Singh JB, Quiroz JA, De Jesus G, Denicoff KK, Luckenbaugh DA, Manji HK, Charney DS. A double-blind, placebo-controlled study of memantine in the treatment of major depression. The American Journal of Psychiatry. 163: 153-5. PMID 16390905 DOI: 10.1176/Appi.Ajp.163.1.153 |
0.399 |
|
| 2006 |
Nugent AC, Milham MP, Bain EE, Mah L, Cannon DM, Marrett S, Zarate CA, Pine DS, Price JL, Drevets WC. Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry. Neuroimage. 30: 485-97. PMID 16256376 DOI: 10.1016/J.Neuroimage.2005.09.029 |
0.336 |
|
| 2006 |
Kronstein PD, Zarate CA. The acute treatment of bipolar depression: Historically relevant and recent controlled trials Current Psychosis & Therapeutics Reports. 4: 151-158. DOI: 10.1007/Bf02629389 |
0.485 |
|
| 2005 |
Erickson K, Drevets WC, Clark L, Cannon DM, Bain EE, Zarate CA, Charney DS, Sahakian BJ. Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder. The American Journal of Psychiatry. 162: 2171-3. PMID 16263859 DOI: 10.1176/Appi.Ajp.162.11.2171 |
0.449 |
|
| 2005 |
Zhou R, Zarate CA, Manji HK. Identification of molecular mechanisms underlying mood stabilization through genome-wide gene expression profiling. The International Journal of Neuropsychopharmacology. 9: 263-6. PMID 16207389 DOI: 10.1017/S1461145705006176 |
0.311 |
|
| 2005 |
Zarate CA, Quiroz JA, Singh JB, Denicoff KD, De Jesus G, Luckenbaugh DA, Charney DS, Manji HK. An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biological Psychiatry. 57: 430-2. PMID 15705360 DOI: 10.1016/J.Biopsych.2004.11.023 |
0.463 |
|
| 2005 |
Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Molecular Psychiatry. 9: 734-55. PMID 15136794 DOI: 10.1038/Sj.Mp.4001518 |
0.351 |
|
| 2005 |
Zarate CA, Singh JB, Carlson PJ, Manji HK. Molecular mechanisms of bipolar disorder Drug Discovery Today: Disease Mechanisms. 2: 435-445. DOI: 10.1016/J.Ddmec.2005.11.005 |
0.351 |
|
| 2004 |
Du J, Quiroz J, Yuan P, Zarate C, Manji HK. Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses. Neuron Glia Biology. 1: 231-43. PMID 18634600 DOI: 10.1017/S1740925X05000098 |
0.36 |
|
| 2004 |
Zarate CA, Payne JL, Singh J, Quiroz JA, Luckenbaugh DA, Denicoff KD, Charney DS, Manji HK. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biological Psychiatry. 56: 54-60. PMID 15219473 DOI: 10.1016/J.Biopsych.2004.03.013 |
0.488 |
|
| 2004 |
Tohen M, Chengappa KN, Suppes T, Baker RW, Zarate CA, Bowden CL, Sachs GS, Kupfer DJ, Ghaemi SN, Feldman PD, Risser RC, Evans AR, Calabrese JR. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. The British Journal of Psychiatry : the Journal of Mental Science. 184: 337-45. PMID 15056579 DOI: 10.1192/Bjp.184.4.337 |
0.347 |
|
| 2004 |
McElroy SL, Zarate CA, Cookson J, Suppes T, Huffman RF, Greene P, Ascher J. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. The Journal of Clinical Psychiatry. 65: 204-10. PMID 15003074 DOI: 10.4088/Jcp.V65N0210 |
0.458 |
|
| 2004 |
Singh J, Zarate CA, Krystal AD. Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine. Psychopharmacology. 173: 227-8. PMID 14722708 DOI: 10.1007/S00213-003-1756-8 |
0.411 |
|
| 2004 |
Zarate CA, Payne JL, Quiroz J, Sporn J, Denicoff KK, Luckenbaugh D, Charney DS, Manji HK. An open-label trial of riluzole in patients with treatment-resistant major depression. The American Journal of Psychiatry. 161: 171-4. PMID 14702270 DOI: 10.1176/Appi.Ajp.161.1.171 |
0.457 |
|
| 2004 |
Tohen M, Zarate CA, Hennen J, Khalsa HM, Strakowski SM, Gebre-Medhin P, Salvatore P, Baldessarini RJ. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. The American Journal of Psychiatry. 160: 2099-107. PMID 14638578 DOI: 10.1176/Appi.Ajp.160.12.2099 |
0.303 |
|
| 2004 |
Gould TD, Zarate CA, Manji HK. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments. The Journal of Clinical Psychiatry. 65: 10-21. DOI: 10.1002/0470052171.Ch7 |
0.319 |
|
| 2003 |
Baldessarini RJ, Hennen J, Wilson M, Calabrese J, Chengappa R, Keck PE, McElroy SL, Sachs G, Vieta E, Welge JA, Yatham LN, Zarate CA, Baker RW, Tohen M. Olanzapine versus placebo in acute mania: treatment responses in subgroups. Journal of Clinical Psychopharmacology. 23: 370-6. PMID 12920413 DOI: 10.1097/01.Jcp.0000085410.08426.9A |
0.307 |
|
| 2003 |
Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh LM, Risser RC, Brown E, Baker RW. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. The American Journal of Psychiatry. 160: 1263-71. PMID 12832240 DOI: 10.1176/Appi.Ajp.160.7.1263 |
0.313 |
|
| 2003 |
Zarate CA, Quiroz JA. Combination treatment in bipolar disorder: a review of controlled trials. Bipolar Disorders. 5: 217-25. PMID 12780875 DOI: 10.1034/J.1399-5618.2003.00034.X |
0.331 |
|
| 2003 |
Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, A Gray N, Zarate CA, Charney DS. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biological Psychiatry. 53: 707-42. PMID 12706957 DOI: 10.1016/S0006-3223(03)00117-3 |
0.424 |
|
| 2002 |
Tohen M, Baker RW, Altshuler LL, Zarate CA, Suppes T, Ketter TA, Milton DR, Risser R, Gilmore JA, Breier A, Tollefson GA. Olanzapine versus divalproex in the treatment of acute mania. The American Journal of Psychiatry. 159: 1011-7. PMID 12042191 DOI: 10.1176/Appi.Ajp.159.6.1011 |
0.353 |
|
| 2002 |
Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Archives of General Psychiatry. 59: 62-9. PMID 11779284 DOI: 10.1001/Archpsyc.59.1.62 |
0.34 |
|
| 2002 |
Tohen M, Baker R, Altshuler L, Zarate C, Suppes T, Ketter T, Risser R, Brown E, Luther M, Gilmore J, Schuh L. Olanzapine versus divalproex sodium for bipolar mania: a 47-week study European Psychiatry. 17: 109. DOI: 10.1016/S0924-9338(02)80488-6 |
0.329 |
|
| 2001 |
Zarate CA, Tohen M, Fletcher K. Cycling into depression from a first episode of mania: a case-comparison study. The American Journal of Psychiatry. 158: 1524-6. PMID 11532746 DOI: 10.1176/Appi.Ajp.158.9.1524 |
0.435 |
|
| 2000 |
Green AI, Tohen M, Patel JK, Banov M, DuRand C, Berman I, Chang H, Zarate C, Posener J, Lee H, Dawson R, Richards C, Cole JO, Schatzberg AF. Clozapine in the treatment of refractory psychotic mania. The American Journal of Psychiatry. 157: 982-6. PMID 10831480 DOI: 10.1176/Appi.Ajp.157.6.982 |
0.334 |
|
| 1999 |
Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, Wible CG, Fischer IA, Yurgelun-Todd D, Zarate C, Kikinis R, Jolesz FA, McCarley RW. Subgenual cingulate cortex volume in first-episode psychosis. The American Journal of Psychiatry. 156: 1091-3. PMID 10401458 DOI: 10.1176/Ajp.156.7.1091 |
0.339 |
|
| 1996 |
Pillay SS, Stoll AL, Weiss MK, Tohen M, Zarate CA, Banov MD, Cole JO. EEG abnormalities before clozapine therapy predict a good clinical response to clozapine. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 8: 1-5. PMID 8743641 DOI: 10.3109/10401239609149083 |
0.312 |
|
| Show low-probability matches. |